Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	alpha-glucosidase activity	GANAB MGAM2 MGAM	8.22e-05	7	270	3	GO:0090599
GeneOntologyMolecularFunction	3-phosphoinositide-dependent protein kinase activity	PDPK1 PDPK2P	1.82e-04	2	270	2	GO:0004676
GeneOntologyMolecularFunction	glucan 1,4-alpha-glucosidase activity	MGAM2 MGAM	1.82e-04	2	270	2	GO:0004339
GeneOntologyMolecularFunction	calcium ion binding	DCHS2 DLK1 ADGRV1 PCDH17 CEMIP2 EHD2 CPNE6 FBN1 MMP8 HSPG2 FAT4 CABP2 STAB2 DSC3 CUBN PITPNM1 EDEM3 THBS3 PKD2L2 SLC25A13 PAM DSG4 PCDH9	2.29e-04	749	270	23	GO:0005509
Domain	-	VSIG2 HAPLN2 LRRC4 IL18RAP F3 EBF2 IGSF10 PXDN PTPRD NFATC2 NFKB1 ALCAM FLRT2 USH2A IGSF3 CDON HSPG2 LILRA2 SDK2 MXRA5 EBF3 ROR2 EBF1 TRIM3 CSF1R CSF3R HAPLN3 SORL1	3.81e-07	663	269	28	2.60.40.10
Domain	Ig-like_fold	VSIG2 HAPLN2 LRRC4 IL18RAP F3 EBF2 IGSF10 PXDN PTPRD NFATC2 NFKB1 ALCAM FLRT2 USH2A IGSF3 CDON HSPG2 LILRA2 SDK2 MXRA5 EBF3 ROR2 EBF1 TRIM3 CSF1R CSF3R HAPLN3 SORL1	1.32e-06	706	269	28	IPR013783
Domain	IGc2	VSIG2 LRRC4 IGSF10 PXDN PTPRD ALCAM IGSF3 CDON HSPG2 LILRA2 SDK2 MXRA5 ROR2 CSF1R	8.40e-06	235	269	14	SM00408
Domain	Ig_sub2	VSIG2 LRRC4 IGSF10 PXDN PTPRD ALCAM IGSF3 CDON HSPG2 LILRA2 SDK2 MXRA5 ROR2 CSF1R	8.40e-06	235	269	14	IPR003598
Domain	Transcription_factor_COE	EBF2 EBF3 EBF1	1.17e-05	4	269	3	IPR003523
Domain	COE	EBF2 EBF3 EBF1	1.17e-05	4	269	3	PS01345
Domain	COE_HLH	EBF2 EBF3 EBF1	1.17e-05	4	269	3	IPR032201
Domain	COE_DBD	EBF2 EBF3 EBF1	1.17e-05	4	269	3	IPR032200
Domain	Transcription_factor_COE_CS	EBF2 EBF3 EBF1	1.17e-05	4	269	3	IPR018350
Domain	COE1_HLH	EBF2 EBF3 EBF1	1.17e-05	4	269	3	PF16423
Domain	COE1_DBD	EBF2 EBF3 EBF1	1.17e-05	4	269	3	PF16422
Domain	IPT	EBF2 NFATC2 NFKB1 EBF3 EBF1	3.72e-05	27	269	5	SM00429
Domain	Glyco_hydro_31_AS	GANAB MGAM2 MGAM	5.72e-05	6	269	3	IPR030458
Domain	TRP_2	TRPC3 TRPC6 TRPC7	5.72e-05	6	269	3	PF08344
Domain	TRP_dom	TRPC3 TRPC6 TRPC7	5.72e-05	6	269	3	IPR013555
Domain	TIG	EBF2 NFATC2 NFKB1 EBF3 EBF1	7.47e-05	31	269	5	PF01833
Domain	IPT	EBF2 NFATC2 NFKB1 EBF3 EBF1	8.75e-05	32	269	5	IPR002909
Domain	Glyco_hydro_31	GANAB MGAM2 MGAM	9.91e-05	7	269	3	PF01055
Domain	GLYCOSYL_HYDROL_F31_1	GANAB MGAM2 MGAM	9.91e-05	7	269	3	PS00129
Domain	Glyco_hydro_31	GANAB MGAM2 MGAM	9.91e-05	7	269	3	IPR000322
Domain	TRPC_channel	TRPC3 TRPC6 TRPC7	9.91e-05	7	269	3	IPR002153
Domain	IGv	VSIG2 HAPLN2 IGSF10 ALCAM IGSF3 HSPG2 HAPLN3	1.02e-04	75	269	7	SM00406
Domain	IG	VSIG2 HAPLN2 LRRC4 IL18RAP IGSF10 PXDN PTPRD ALCAM IGSF3 CDON HSPG2 LILRA2 SDK2 MXRA5 ROR2 CSF1R HAPLN3	1.38e-04	421	269	17	SM00409
Domain	Ig_sub	VSIG2 HAPLN2 LRRC4 IL18RAP IGSF10 PXDN PTPRD ALCAM IGSF3 CDON HSPG2 LILRA2 SDK2 MXRA5 ROR2 CSF1R HAPLN3	1.38e-04	421	269	17	IPR003599
Domain	M14A_act_pep	CPA4 CPA5 CPA1	1.57e-04	8	269	3	IPR003146
Domain	-	CPA4 CPA5 CPA1	1.57e-04	8	269	3	3.30.70.340
Domain	DHC_N1	DNAH5 DNAH9 DNAH10	1.57e-04	8	269	3	PF08385
Domain	Propep_M14	CPA4 CPA5 CPA1	1.57e-04	8	269	3	PF02244
Domain	Dynein_heavy_dom-1	DNAH5 DNAH9 DNAH10	1.57e-04	8	269	3	IPR013594
Domain	Med13_C	MED13 MED13L	2.07e-04	2	269	2	PF06333
Domain	GREB1	GREB1L GREB1	2.07e-04	2	269	2	PF15782
Domain	GREB1	GREB1L GREB1	2.07e-04	2	269	2	IPR028422
Domain	Med13_N	MED13 MED13L	2.07e-04	2	269	2	PF11597
Domain	Mediator_Med13_N_met/fun	MED13 MED13L	2.07e-04	2	269	2	IPR021643
Domain	Mediator_Med13	MED13 MED13L	2.07e-04	2	269	2	IPR009401
Domain	-	BAAT PGAP1 ABHD1 ABHD14A NLGN4Y NLGN1 ABHD12 ABHD11	3.30e-04	119	269	8	3.40.50.1820
Domain	AB_hydrolase	BAAT PGAP1 ABHD1 ABHD14A NLGN4Y NLGN1 ABHD12 ABHD11	3.30e-04	119	269	8	IPR029058
Domain	Ig-like_dom	VSIG2 HAPLN2 LRRC4 IL18RAP IGSF10 PXDN PTPRD ALCAM IGSF3 CDON HSPG2 LILRA2 SDK2 MXRA5 ROR2 CSF1R CSF3R HAPLN3	3.86e-04	503	269	18	IPR007110
Domain	Ig_I-set	VSIG2 LRRC4 IGSF10 PXDN PTPRD CDON HSPG2 SDK2 MXRA5 ROR2	4.46e-04	190	269	10	IPR013098
Domain	I-set	VSIG2 LRRC4 IGSF10 PXDN PTPRD CDON HSPG2 SDK2 MXRA5 ROR2	4.46e-04	190	269	10	PF07679
Domain	TRP_channel	TRPC3 TRPC6 TRPC7	4.48e-04	11	269	3	IPR004729
Domain	EGF	RELN DLK1 MEP1A FBN1 FCGBP HSPG2 FAT4 STAB2 CUBN THBS3 SORL1	6.29e-04	235	269	11	SM00181
Domain	Link_dom	HAPLN2 STAB2 HAPLN3	7.59e-04	13	269	3	IPR000538
Domain	Xlink	HAPLN2 STAB2 HAPLN3	7.59e-04	13	269	3	PF00193
Domain	LINK_2	HAPLN2 STAB2 HAPLN3	7.59e-04	13	269	3	PS50963
Domain	LINK	HAPLN2 STAB2 HAPLN3	7.59e-04	13	269	3	SM00445
Domain	LINK_1	HAPLN2 STAB2 HAPLN3	7.59e-04	13	269	3	PS01241
Domain	IG_LIKE	VSIG2 HAPLN2 LRRC4 IL18RAP IGSF10 PXDN PTPRD ALCAM IGSF3 CDON HSPG2 LILRA2 SDK2 MXRA5 ROR2 CSF1R HAPLN3	8.05e-04	491	269	17	PS50835
Domain	ATPase_dyneun-rel_AAA	DNAH5 DNAH9 DNAH10	9.56e-04	14	269	3	IPR011704
Domain	MT	DNAH5 DNAH9 DNAH10	9.56e-04	14	269	3	PF12777
Domain	AAA_8	DNAH5 DNAH9 DNAH10	9.56e-04	14	269	3	PF12780
Domain	AAA_5	DNAH5 DNAH9 DNAH10	9.56e-04	14	269	3	PF07728
Domain	Dynein_heavy_chain_D4_dom	DNAH5 DNAH9 DNAH10	9.56e-04	14	269	3	IPR024317
Domain	Dynein_HC_stalk	DNAH5 DNAH9 DNAH10	9.56e-04	14	269	3	IPR024743
Domain	Dynein_heavy_dom-2	DNAH5 DNAH9 DNAH10	9.56e-04	14	269	3	IPR013602
Domain	DHC_N2	DNAH5 DNAH9 DNAH10	9.56e-04	14	269	3	PF08393
Domain	EGF-like_dom	RELN DLK1 MEP1A FBN1 FCGBP HSPG2 FAT4 STAB2 CUBN THBS3 SORL1	1.01e-03	249	269	11	IPR000742
Domain	AAA+_ATPase	MCM7 ABCB4 DHX15 DNAH5 DNAH9 DNAH10 NSF ABCC12	1.16e-03	144	269	8	IPR003593
Domain	AAA	MCM7 ABCB4 DHX15 DNAH5 DNAH9 DNAH10 NSF ABCC12	1.16e-03	144	269	8	SM00382
Domain	DHC_fam	DNAH5 DNAH9 DNAH10	1.18e-03	15	269	3	IPR026983
Domain	Dynein_heavy	DNAH5 DNAH9 DNAH10	1.18e-03	15	269	3	PF03028
Domain	Dynein_heavy_dom	DNAH5 DNAH9 DNAH10	1.18e-03	15	269	3	IPR004273
Domain	Glyco_hydro_31_CS	GANAB MGAM	1.22e-03	4	269	2	IPR030459
Domain	G8	CEMIP2 CEMIP	1.22e-03	4	269	2	PS51484
Domain	Gal_mutarotase_N	MGAM2 MGAM	1.22e-03	4	269	2	IPR031727
Domain	G8	CEMIP2 CEMIP	1.22e-03	4	269	2	PF10162
Domain	G8_domain	CEMIP2 CEMIP	1.22e-03	4	269	2	IPR019316
Domain	G8	CEMIP2 CEMIP	1.22e-03	4	269	2	SM01225
Domain	NtCtMGAM_N	MGAM2 MGAM	1.22e-03	4	269	2	PF16863
Domain	AB_hydrolase_1	ABHD1 ABHD14A ABHD12 ABHD11	1.24e-03	33	269	4	IPR000073
Domain	Gal_mutarotase_SF_dom	GANAB MGAM2 MGAM	1.73e-03	17	269	3	IPR011013
Domain	Propept_inh	CPA4 CPA5 CPA1	1.73e-03	17	269	3	IPR009020
Domain	Cys-rich_flank_reg_C	LRRC4 IGSF10 PXDN FLRT2 MXRA5 TPBG	1.91e-03	90	269	6	IPR000483
Domain	LRRCT	LRRC4 IGSF10 PXDN FLRT2 MXRA5 TPBG	1.91e-03	90	269	6	SM00082
Domain	EGF_CA	DLK1 FBN1 HSPG2 FAT4 STAB2 CUBN THBS3	1.95e-03	122	269	7	SM00179
Domain	Abhydrolase_6	ABHD14A ABHD11	2.01e-03	5	269	2	PF12697
Domain	GLYCOSYL_HYDROL_F31_2	GANAB MGAM	2.01e-03	5	269	2	PS00707
Domain	VWA_2	CLCA1 INTS6L	2.01e-03	5	269	2	PF13519
Domain	Nlgn	NLGN4Y NLGN1	2.01e-03	5	269	2	IPR000460
Domain	Zn_pept	CPA4 CPA5 CPA1	2.05e-03	18	269	3	SM00631
Domain	EGF-like_Ca-bd_dom	DLK1 FBN1 HSPG2 FAT4 STAB2 CUBN THBS3	2.14e-03	124	269	7	IPR001881
Domain	EGF_3	RELN DLK1 MEP1A FBN1 HSPG2 FAT4 STAB2 CUBN THBS3 SORL1	2.23e-03	235	269	10	PS50026
Domain	CARBOXYPEPT_ZN_2	CPA4 CPA5 CPA1	2.41e-03	19	269	3	PS00133
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	MYH10 SETD1B MYO10 RAP1GAP2 CSMD3 GANAB KIF3B PXDN STARD9 RAB3GAP2 RRP12 CLTC SLC23A2 DOP1B EP400 ADGRL1 NLGN1 MED13L SYVN1 SPATA13	1.27e-10	407	276	20	12693553
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	PIGN GLT8D1 PIEZO1 WDR25 CEMIP2 DHX15 IGSF10 FBN1 GANAB PXDN TM9SF2 PGAP1 RRP12 CPSF1 TXNDC16 ALCAM IGSF3 CDON LRRC8C HSPG2 FAT4 ROR2 GRIK2 HACD2 EDEM3 THBS3 UHRF1 PAM ABHD12 G6PD SORL1	9.79e-09	1201	276	31	35696571
Pubmed	TRPC channels are necessary mediators of pathologic cardiac hypertrophy.	TRPC3 TRPC6 NFATC2 TRPC7	1.93e-08	5	276	4	20351294
Pubmed	Early B-cell factors 2 and 3 (EBF2/3) regulate early migration of Cajal-Retzius cells from the cortical hem.	RELN EBF2 WNT3A EBF3 EBF1	3.71e-08	13	276	5	22421355
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	CAND1 KDM5C PIEZO1 ADGRV1 CEMIP2 MAST4 ARL6IP1 TECPR2 SYNJ2 MED13 IGSF3 SDK2 EP400 AKNA NAT10 SENP6 NUP188 RIMS2 DHX34	5.94e-08	529	276	19	14621295
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	SETD1B MYO10 PIEZO1 RAP1GAP2 CARD10 BCL9 WNK1 CABLES1 PIK3CD RRP12 ZNF398 CPSF1 DMWD MED13 IGSF3 BAHCC1 HSPG2 EP400 AKNA ADGRL1 MED13L NR2F2 MROH6 SBF2 NUP188 SYVN1 DHX34 SPATA13	7.81e-08	1105	276	28	35748872
Pubmed	The characterization of the Olf-1/EBF-like HLH transcription factor family: implications in olfactory gene regulation and neuronal development.	EBF2 EBF3 EBF1	4.94e-07	3	276	3	9151732
Pubmed	Major contribution of the 3/6/7 class of TRPC channels to myocardial ischemia/reperfusion and cellular hypoxia/reoxygenation injuries.	TRPC3 TRPC6 TRPC7	4.94e-07	3	276	3	28526717
Pubmed	Expression of the immunoglobulin superfamily cell adhesion molecules in the developing spinal cord and dorsal root ganglion.	VSIG2 LRRC4 IGSF10 PXDN PTPRD ALCAM IGSF3 CDON ROR2 CSF1R	7.55e-07	162	276	10	25826454
Pubmed	Heterogeneous distribution of TRPC proteins in the embryonic cortex.	RELN TRPC3 TRPC6 TRPC7	7.85e-07	10	276	4	18989690
Pubmed	Activation of ERK and NF-κB during HARE-Mediated Heparin Uptake Require Only One of the Four Endocytic Motifs.	NFKB1 STAB2 MAPK3	1.97e-06	4	276	3	27100626
Pubmed	Melanopsin Phototransduction Is Repurposed by ipRGC Subtypes to Shape the Function of Distinct Visual Circuits.	TRPC3 TRPC6 TRPC7	1.97e-06	4	276	3	30017393
Pubmed	Cloning and functional characterization of Roaz, a zinc finger protein that interacts with O/E-1 to regulate gene expression: implications for olfactory neuronal development.	EBF2 EBF3 EBF1	1.97e-06	4	276	3	9151733
Pubmed	Coexistence of two forms of LTP in ACC provides a synaptic mechanism for the interactions between anxiety and chronic pain.	ADCY8 GRIK1 GRIK2	1.97e-06	4	276	3	25556835
Pubmed	Cloning of a novel Olf-1/EBF-like gene, O/E-4, by degenerate oligo-based direct selection.	EBF2 EBF3 EBF1	1.97e-06	4	276	3	12139918
Pubmed	Genetic evidence for the requirement of adenylyl cyclase 1 in synaptic scaling of forebrain cortical neurons.	ADCY8 GRIK1 GRIK2	1.97e-06	4	276	3	17650106
Pubmed	Phosphoinositide-dependent kinase 1 provides negative feedback inhibition to Toll-like receptor-mediated NF-kappaB activation in macrophages.	PDPK1 NFKB1 PDPK2P	1.97e-06	4	276	3	20584979
Pubmed	Melanopsin signalling in mammalian iris and retina.	TRPC3 TRPC6 TRPC7 CRY1	2.62e-06	13	276	4	22051675
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	MYH10 CAND1 SETD1B MYO10 KDM5C CHKA WNK1 GANAB RAB3GAP2 CLTC CPSF1 DKC1 MAGEB17 MED13 TAFAZZIN NRBP1 ABHD14A FPGS POLR2B GRIK2 HACD2 MED13L ZC3H7A SLC25A13 NUP188 SKA3 SYVN1 ABHD11	2.91e-06	1327	276	28	32694731
Pubmed	Docking motif-guided mapping of the interactome of protein phosphatase-1.	ZBTB38 MCM7 WNK1 SH3RF2 TMEM132D CSMD1 HYDIN	3.56e-06	80	276	7	19389623
Pubmed	An approach based on a genome-wide association study reveals candidate loci for narcolepsy.	MYH10 TRPC3 BAAT ADCY8 BRCA2 NFATC2 NLGN1 HACD2 SLC18A2 GAB1	3.67e-06	193	276	10	20677014
Pubmed	Formation of whisker-related principal sensory nucleus-based lemniscal pathway requires a paired homeodomain transcription factor, Drg11.	EBF2 EBF3 EBF1	4.89e-06	5	276	3	12917357
Pubmed	Expression patterns of the coe/ebf transcription factor genes during chicken and mouse limb development.	EBF2 EBF3 EBF1	4.89e-06	5	276	3	15261831
Pubmed	Factor Xa induces tissue factor expression in endothelial cells by P44/42 MAPK and NF-κB-dependent pathways.	F3 NFKB1 MAPK3	4.89e-06	5	276	3	20451919
Pubmed	Intrinsic phototransduction persists in melanopsin-expressing ganglion cells lacking diacylglycerol-sensitive TRPC subunits.	TRPC3 TRPC6 TRPC7	4.89e-06	5	276	3	21261756
Pubmed	IκB kinase 2 regulates TPL-2 activation of extracellular signal-regulated kinases 1 and 2 by direct phosphorylation of TPL-2 serine 400.	NFKB1 MAP3K8 MAPK3	4.89e-06	5	276	3	22988300
Pubmed	Circular rapid amplification of cDNA ends for high-throughput extension cloning of partial genes.	ADGRV1 WNK1 FCGBP SDK2 MXRA5 CSF1R CSMD1	4.94e-06	84	276	7	15203218
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	STAM2 SETD1B KDM5C MCM7 WNK1 BRCA2 CLTC RBM14 EP400 RNASEH2A TBC1D8 ZC3H7A MTR SENP6 CDC20 GAB1 SORL1	5.64e-06	588	276	17	38580884
Pubmed	High-resolution photocatalytic mapping of SARS-CoV-2 spike interactions on the cell surface.	PDPK1 CABLES1 PTPRD SLAIN1 ALCAM IGSF3 TUT4 ARHGAP23 ROR2 CRY1 DHX34 TPBG	7.29e-06	307	276	12	37499664
Pubmed	The European renal genome project: an integrated approach towards understanding the genetics of kidney development and disease.	TRPC3 SLC22A7 EBF2 PTPRD NFATC2 TRPC7 EBF3 ROR2 SLC6A1 SORL1	8.41e-06	212	276	10	19521566
Pubmed	PDK1 Deficit Impairs the Development of the Dentate Gyrus in Mice.	RELN PDPK1 WNT3A PDPK2P	8.51e-06	17	276	4	29420689
Pubmed	PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells.	PDPK1 PIK3CD PDPK2P	9.71e-06	6	276	3	23183047
Pubmed	Family of Ebf/Olf-1-related genes potentially involved in neuronal differentiation and regional specification in the central nervous system.	EBF2 EBF3 EBF1	9.71e-06	6	276	3	9389446
Pubmed	Involvement of ERK1/2/NF-κB signal transduction pathway in TF/FVIIa/PAR2-induced proliferation and migration of colon cancer cell SW620.	F3 NFKB1 MAPK3	9.71e-06	6	276	3	21625939
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	MYH10 CAND1 MCM7 PTBP1 DHX15 GANAB TM9SF2 STARD9 RAB3GAP2 RRP12 CLTC RBM14 CPSF1 DKC1 DNAH5 CLUH SEC23A MGAM2 DNAH10 COPG1 NSF POLR2B SLC25A13 NAT10 MTR UHRF1 NUP188 G6PD	1.09e-05	1425	276	28	30948266
Pubmed	Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry.	STAM2 PDPK1 NFATC2 RBM14 ADGRL1 LCK MAPK3 SKA3	1.18e-05	133	276	8	15144186
Pubmed	MxA, a member of the dynamin superfamily, interacts with the ankyrin-like repeat domain of TRPC.	TRPC3 TRPC6 TRPC7	1.69e-05	7	276	3	15757897
Pubmed	TRPC absence induces pro-inflammatory macrophages and gut microbe disorder, sensitizing mice to colitis.	TRPC3 TRPC6 TRPC7	1.69e-05	7	276	3	36592529
Pubmed	Functional role of TRPC proteins in vivo: lessons from TRPC-deficient mouse models.	TRPC3 TRPC6 TRPC7	1.69e-05	7	276	3	15336983
Pubmed	IκB kinase-induced interaction of TPL-2 kinase with 14-3-3 is essential for Toll-like receptor activation of ERK-1 and -2 MAP kinases.	NFKB1 MAP3K8 MAPK3	1.69e-05	7	276	3	24912162
Pubmed	RNA-seq analysis reveals TRPC genes to impact an unexpected number of metabolic and regulatory pathways.	TRPC3 TRPC6 TRPC7	1.69e-05	7	276	3	32350291
Pubmed	TRPC absence induces pro-inflammatory macrophage polarization to promote obesity and exacerbate colorectal cancer.	TRPC3 TRPC6 TRPC7	1.69e-05	7	276	3	38835669
Pubmed	Protein kinase B controls transcriptional programs that direct cytotoxic T cell fate but is dispensable for T cell metabolism.	PDPK1 PIK3CD PDPK2P	1.69e-05	7	276	3	21295499
Pubmed	Subunit composition, molecular environment, and activation of native TRPC channels encoded by their interactomes.	TRPC3 TRPC6 TRPC7	1.69e-05	7	276	3	36257322
Pubmed	Ebf factors and MyoD cooperate to regulate muscle relaxation via Atp2a1.	EBF2 EBF3 EBF1	1.69e-05	7	276	3	24786561
Pubmed	Sensitivity of TLR4- and -7-induced NF kappa B1 p105-TPL2-ERK pathway to TNF-receptor-associated-factor-6 revealed by RNAi in mouse macrophages.	NFKB1 MAP3K8 MAPK3	1.69e-05	7	276	3	17507094
Pubmed	A key role for the HLH transcription factor EBF2COE2,O/E-3 in Purkinje neuron migration and cerebellar cortical topography.	RELN EBF2 EBF3 EBF1	1.70e-05	20	276	4	16774995
Pubmed	The Tbr2 Molecular Network Controls Cortical Neuronal Differentiation Through Complementary Genetic and Epigenetic Pathways.	EBF2 ZBTB18 EBF3 EBF1	2.09e-05	21	276	4	27600842
Pubmed	Defining the membrane proteome of NK cells.	PIGN GLT8D1 CAND1 CDS2 MCM7 PTBP1 RETSAT GANAB KIF3B ATP8A1 ARL6IP1 CLTC MED13 LRRC8C KRT2 DNAJC13 AKNA COG8 NAT10 PAM NUP188 SYVN1 DHX34 G6PD	2.36e-05	1168	276	24	19946888
Pubmed	Identification of new ciliary signaling pathways in the brain and insights into neurological disorders.	CDS2 LRRC4 CEMIP2 GPR158 DMWD SLC23A2 ADGRL1 NLGN1 HACD2 TRIM3 SLC6A1 CNNM1 TMEM132D	2.47e-05	405	276	13	38187761
Pubmed	LASP-1: a nuclear hub for the UHRF1-DNMT1-G9a-Snail1 complex.	CLTC KRT2 NAT10 UHRF1	2.54e-05	22	276	4	25982273
Pubmed	Genetic disruptions of O/E2 and O/E3 genes reveal involvement in olfactory receptor neuron projection.	EBF2 EBF3 EBF1	2.69e-05	8	276	3	14993187
Pubmed	Association of immunophilins with mammalian TRPC channels.	TRPC3 TRPC6 TRPC7	2.69e-05	8	276	3	15199065
Pubmed	Subunit composition of mammalian transient receptor potential channels in living cells.	TRPC3 TRPC6 TRPC7	2.69e-05	8	276	3	12032305
Pubmed	Metabolism regulates the spontaneous firing of substantia nigra pars reticulata neurons via KATP and nonselective cation channels.	TRPC3 TRPC6 TRPC7	2.69e-05	8	276	3	25471572
Pubmed	FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2.	MYH10 PTBP1 EHD2 GANAB CLTC RBM14 DKC1 HSPG2 DNAJC13 COPG1 POLR2B ZC3H7A SLC25A13 SBF2 NAT10 UHRF1	2.90e-05	601	276	16	33658012
Pubmed	Chromosomal localization of glutamate receptor genes: relationship to familial amyotrophic lateral sclerosis and other neurological disorders of mice and humans.	COL10A1 GRIK1 GRIK2 LCK	3.05e-05	23	276	4	8464923
Pubmed	Interactome of the Autoimmune Risk Protein ANKRD55.	MYH10 CAND1 MCM7 PTBP1 GANAB CLTC RBM14 COPG1 SLC25A13	3.06e-05	197	276	9	31620119
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	CPA4 MYH10 CAND1 SETD1B MCM7 PTBP1 DHX15 RRP12 CLTC RBM14 CPSF1 DKC1 SEC23A KRT2 DNAJC13 DSC3 EP400 ARHGAP23 COPG1 POLR2B ZC3H7A SLC25A13 NAT10 CDC20 DHX34 G6PD	3.32e-05	1353	276	26	29467282
Pubmed	Large-scale structural analysis of the classical human protein tyrosine phosphatome.	PDPK1 NSF LCK MAPK3 GAB1	3.55e-05	47	276	5	19167335
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	STAM2 MYH10 CEMIP2 GANAB PTPRD NFKB1 RRP12 CLTC CPSF1 DMWD KRT2 DNAJC13 DSC3 POLR2B DUSP9 TFAP2A CNNM1 SBF2 NAT10 MAPK3 G6PD GAB1	3.84e-05	1049	276	22	27880917
Pubmed	Identification of common binding sites for calmodulin and inositol 1,4,5-trisphosphate receptors on the carboxyl termini of trp channels.	TRPC3 TRPC6 TRPC7	4.01e-05	9	276	3	11290752
Pubmed	Cellular subtype distribution and developmental regulation of TRPC channel members in the mouse dorsal root ganglion.	TRPC3 TRPC6 TRPC7	4.01e-05	9	276	3	17480026
Pubmed	The protein interaction landscape of the human CMGC kinase group.	CAND1 PDPK1 MCM7 PTBP1 CABLES1 DHX15 RBM14 CPSF1 MED13 EP400 POLR2B DUSP9 MED13L MTR NUP188 MAPK3 SORL1	4.72e-05	695	276	17	23602568
Pubmed	In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.	MYH10 CAND1 ABCB4 CPNE6 FCGBP GANAB ATP8A1 PXDN PTPRD CLTC FLRT2 DOP1B KRT2 HSPG2 MGAM FAT4 CP CUBN PAM BPIFB2 G6PD SERPINA5	5.14e-05	1070	276	22	23533145
Pubmed	The leak channel NALCN controls tonic firing and glycolytic sensitivity of substantia nigra pars reticulata neurons.	TRPC3 TRPC6 TRPC7	5.69e-05	10	276	3	27177420
Pubmed	Prox1 Regulates the Subtype-Specific Development of Caudal Ganglionic Eminence-Derived GABAergic Cortical Interneurons.	RELN WNT3A NR2F2	5.69e-05	10	276	3	26377473
Pubmed	Prenatal correction of IGF2 to rescue the growth phenotypes in mouse models of Beckwith-Wiedemann and Silver-Russell syndromes.	PDPK1 PDPK2P MAPK3	5.69e-05	10	276	3	33567274
Pubmed	An introduction to TRP channels.	TRPC3 TRPC6 TRPC7 PKD2L2	5.90e-05	27	276	4	16460286
Pubmed	Direct interaction between the PRDM3 and PRDM16 tumor suppressors and the NuRD chromatin remodeling complex.	MCM7 DHX15 CLTC RBM14 DKC1 COPG1 SLC25A13 NAT10 UHRF1	6.04e-05	215	276	9	30462309
Pubmed	Epinephrine-induced hyperpolarization of pancreatic islet cells is sensitive to PI3K-PDK1 signaling.	PDPK1 PDPK2P	6.28e-05	2	276	2	19716369
Pubmed	TRPC3 and TRPC6 are essential for normal mechanotransduction in subsets of sensory neurons and cochlear hair cells.	TRPC3 TRPC6	6.28e-05	2	276	2	22724068
Pubmed	Reduced intestinal and renal amino acid transport in PDK1 hypomorphic mice.	PDPK1 PDPK2P	6.28e-05	2	276	2	17077298
Pubmed	3'Phosphoinositide-dependent kinase-1 is essential for ischemic preconditioning of the myocardium.	PDPK1 PDPK2P	6.28e-05	2	276	2	17077284
Pubmed	Mechanisms underlying Myosin 10's contribution to the maintenance of mitotic spindle bipolarity.	MYH10 MYO10	6.28e-05	2	276	2	38019611
Pubmed	NF-kappaB1 p105 negatively regulates TPL-2 MEK kinase activity.	NFKB1 MAP3K8	6.28e-05	2	276	2	12832462
Pubmed	Phosphoinositide-dependent kinase PDK1 in the regulation of Ca2+ entry into mast cells.	PDPK1 PDPK2P	6.28e-05	2	276	2	21063107
Pubmed	Preliminary evidence for a link between schizophrenia and NMDA-glycine site receptor ligand metabolic enzymes, d-amino acid oxidase (DAAO) and kynurenine aminotransferase-1 (KAT-1).	DAO KYAT1	6.28e-05	2	276	2	16828464
Pubmed	Modulation of excitatory synaptic transmission in the spinal substantia gelatinosa of mice deficient in the kainate receptor GluR5 and/or GluR6 subunit.	GRIK1 GRIK2	6.28e-05	2	276	2	14724198
Pubmed	The kainate receptor subunit GluR6 mediates metabotropic regulation of the slow and medium AHP currents in mouse hippocampal neurones.	GRIK1 GRIK2	6.28e-05	2	276	2	15539395
Pubmed	Conditional knockout of the PDK-1 gene in osteoblasts affects osteoblast differentiation and bone formation.	PDPK1 PDPK2P	6.28e-05	2	276	2	33377210
Pubmed	Essential role of PDK1 in regulating endothelial cell migration.	PDPK1 PDPK2P	6.28e-05	2	276	2	17371830
Pubmed	Reduced Ca2+ entry and suicidal death of erythrocytes in PDK1 hypomorphic mice.	PDPK1 PDPK2P	6.28e-05	2	276	2	17899170
Pubmed	Modulation of Transient Receptor Potential Channels 3 and 6 Regulates Osteoclast Function with Impact on Trabecular Bone Loss.	TRPC3 TRPC6	6.28e-05	2	276	2	32140760
Pubmed	Oleamide suppresses lipopolysaccharide-induced expression of iNOS and COX-2 through inhibition of NF-kappaB activation in BV2 murine microglial cells.	FAAH NFKB1	6.28e-05	2	276	2	20298753
Pubmed	Role of PDK1 in regulation of gastric acid secretion.	PDPK1 PDPK2P	6.28e-05	2	276	2	19088454
Pubmed	Phosphatidylinositide dependent kinase deficiency increases anxiety and decreases GABA and serotonin abundance in the amygdala.	PDPK1 PDPK2P	6.28e-05	2	276	2	19088455
Pubmed	Expression and novel subunit isoforms of glutamate receptor genes GluR5 and GluR6.	GRIK1 GRIK2	6.28e-05	2	276	2	8260617
Pubmed	The in vivo role of PtdIns(3,4,5)P3 binding to PDK1 PH domain defined by knockin mutation.	PDPK1 PDPK2P	6.28e-05	2	276	2	15116068
Pubmed	Nonobese diabetic CD4 lymphocytosis maps outside the MHC locus on chromosome 17.	PDPK1 PDPK2P	6.28e-05	2	276	2	15309345
Pubmed	Essential role of PDK1 in regulating cell size and development in mice.	PDPK1 PDPK2P	6.28e-05	2	276	2	12110585
Pubmed	The effect of PDK1 in maintaining immune cell development and function.	PDPK1 PDPK2P	6.28e-05	2	276	2	38795634
Pubmed	Early B Cell Factor Activity Controls Developmental and Adaptive Thermogenic Gene Programming in Adipocytes.	EBF2 EBF1	6.28e-05	2	276	2	32130892
Pubmed	Assessing the role of GLUK5 and GLUK6 at hippocampal mossy fiber synapses.	GRIK1 GRIK2	6.28e-05	2	276	2	15537878
Pubmed	NF-kappaB1/p105 regulates lipopolysaccharide-stimulated MAP kinase signaling by governing the stability and function of the Tpl2 kinase.	NFKB1 MAP3K8	6.28e-05	2	276	2	12667451
Pubmed	Structure-based design of PDK1 inhibitors.	PDPK1 PDPK2P	6.28e-05	2	276	2	22119465
Pubmed	Role of PDK1 in insulin-signaling pathway for glucose metabolism in 3T3-L1 adipocytes.	PDPK1 PDPK2P	6.28e-05	2	276	2	12006370
Pubmed	Nuclear translocation of 3'-phosphoinositide-dependent protein kinase 1 (PDK-1): a potential regulatory mechanism for PDK-1 function.	PDPK1 PDPK2P	6.28e-05	2	276	2	14623982
Pubmed	Asymmetric dimethylarginine induces tissue factor expression in monocytes via NF-kappaB-dependent pathway: Role in acute coronary syndromes.	F3 NFKB1	6.28e-05	2	276	2	19167713
Pubmed	PDK1 Determines Collagen-Dependent Platelet Ca2+ Signaling and Is Critical to Development of Ischemic Stroke In Vivo.	PDPK1 PDPK2P	6.28e-05	2	276	2	27339458
Interaction	RYK interactions	STAM2 PCDH17 PTPRD WNT3A ALCAM SEC23A CDON FAT4 SDK2 DSC3 CNNM1 DSG4 MAPK3 PCDH9	9.70e-07	212	267	14	int:RYK
Interaction	CEACAM8 interactions	ADGRV1 TXNDC16 TAFAZZIN IGSF3 FAT4 SDK2 EDEM3 ENTPD5 PAM HAPLN3	4.22e-06	119	267	10	int:CEACAM8
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	VSIG2 LRRC4 IGSF10 PXDN PTPRD CDON HSPG2 SDK2 MXRA5 ROR2	9.57e-06	161	194	10	593
GeneFamily	Abhydrolase domain containing	ABHD1 ABHD14A ABHD12 ABHD11	8.08e-05	22	194	4	4
GeneFamily	Transient receptor potential cation channels	TRPC3 TRPC6 TRPC7 PKD2L2	2.15e-04	28	194	4	249
GeneFamily	Fibronectin type III domain containing\|USH2 complex	ADGRV1 USH2A	6.78e-04	4	194	2	1244
GeneFamily	Dyneins, axonemal	DNAH5 DNAH9 DNAH10	7.40e-04	17	194	3	536
GeneFamily	Glutamate ionotropic receptor kainate type subunits	GRIK1 GRIK2	1.12e-03	5	194	2	1199
GeneFamily	Immunoglobulin like domain containing	IL18RAP ALCAM IGSF3 CDON HSPG2 SDK2 MXRA5 CSF1R	1.16e-03	193	194	8	594
GeneFamily	Carboxypeptidases	CPA4 CPA5 CPA1	1.40e-03	21	194	3	1321
GeneFamily	Fibronectin type III domain containing	PTPRD FLRT2 USH2A CDON SDK2 CSF3R SORL1	1.72e-03	160	194	7	555
GeneFamily	Desmosomal cadherins	DSC3 DSG4	2.32e-03	7	194	2	1188
GeneFamily	Solute carriers	SLC12A8 SLC22A7 SLC35D1 SLC22A8 SLC23A2 SLC27A5 SLC35F1 SLC6A1 SLC18A2 SLC20A2 SLC25A13	3.68e-03	395	194	11	752
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	RELN ZBTB38 RAP1GAP2 CSMD3 PCDH17 EBF2 ATP8A1 MAST4 RBMS3 GPR158 PIK3CD PGAP1 IGSF3 CDON DOP1B TUT4 ZNF354A ARHGAP23 EBF3 ADGRL1 GRIK1 GRIK2 NLGN1 EBF1 MED13L CEMIP SLC6A1 VWA5A SBF2 VASH2 PAK3 CSMD1 SPAG17 RIMS2 PCDH9 HYDIN SPATA13	4.08e-10	1106	273	37	M39071
Coexpression	FOSTER_TOLERANT_MACROPHAGE_DN	PRR5L MYO10 USP25 BCL9 CEMIP2 PTPRD NFKB1 ALCAM NOCT MAP3K8 XKR8 CP LCK MED13L ZC3H7A SPATA13 TPBG	2.15e-06	418	273	17	M12676
Coexpression	FOSTER_TOLERANT_MACROPHAGE_DN	PRR5L MYO10 USP25 BCL9 CEMIP2 PTPRD NFKB1 ALCAM NOCT MAP3K8 XKR8 CP LCK MED13L ZC3H7A SPATA13 TPBG	3.66e-06	435	273	17	MM1221
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	CAND1 MYO10 CDS2 F3 BICD1 DHX15 BRCA2 SYNJ2 NFKB1 ALCAM FLRT2 ZBTB18 SLC23A2 MED13 DOP1B DNAJC13 TUT4 POLR2B MED13L NR2F2 CEMIP CRY1 SLC20A2 SLC25A13 MTR	3.92e-06	856	273	25	M4500
Coexpression	HE_LIM_SUN_FETAL_LUNG_C3_SCG3_POS_LYMPHATIC_ENDOTHELIAL_CELL	NIT2 RHOBTB1 NFATC2 STARD9 FLRT2 IGSF3 DOP1B NLGN4Y EBF1 HACD2 ATP10D PITPNM1 TBC1D8 THBS3 PDGFD PAK3 GREB1 RINL GAB1 TPBG	6.19e-06	604	273	20	M45760
Coexpression	MILI_PSEUDOPODIA_CHEMOTAXIS_DN	CDS2 CHKA BCL9 GPR108 F3 GANAB MAST4 TM9SF2 SLC23A2 IGSF3 LRRC8C THBS3 SLC20A2 PAM SYVN1 ABHD12 TPBG	7.01e-06	457	273	17	M1613
Coexpression	NABA_CORE_MATRISOME	RELN HAPLN2 IGSF10 FBN1 PXDN USH2A INTS6L HSPG2 COL10A1 MXRA5 THBS3 VWA5A HAPLN3	7.02e-06	275	273	13	M5884
Coexpression	MILI_PSEUDOPODIA_CHEMOTAXIS_DN	CDS2 CHKA BCL9 GPR108 F3 GANAB MAST4 TM9SF2 SLC23A2 IGSF3 LRRC8C THBS3 SLC20A2 PAM SYVN1 ABHD12 TPBG	1.01e-05	470	273	17	MM1053
Coexpression	RIGGI_EWING_SARCOMA_PROGENITOR_UP	RELN PRR5L MYO10 UGT3A1 PCDH17 EBF2 CLCA1 SLAIN1 FLRT2 MMP8 IGSF3 FAT4 GRIK2 RSPH3 PCDH9 SPATA13	1.59e-05	437	273	16	M15981
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HRGL2C	RELN CHKA CSMD3 F3 PCDH17 NFATC2 NLGN4Y SLC6A1 UHRF1 HAPLN3 SKA3 CSMD1 SPAG17	4.06e-05	325	273	13	M39053
Coexpression	GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN	NFATC2 SYNJ2 ZNF398 CDON LCK MED13L ATP10D UBXN11 SBF2 ENTPD5	4.84e-05	199	273	10	M6030
Coexpression	GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_DN	RELN CDS2 CHKB ATP8A1 PGAP1 CARD6 TXNDC16 INTS6L MED13L ZC3H7A	5.05e-05	200	273	10	M8956
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000	MYO10 PIEZO1 TRPC3 TRPC6 DLK1 CHKA GREB1L IGSF10 FBN1 CLCA1 PXDN PTPRD BRCA2 STARD9 ALCAM CNGA1 TUT4 CPA1 GPAM NR2F2 CRY1 ENTPD5 PAK3 UHRF1 HAPLN3 G6PD PCDH9	1.71e-06	768	268	27	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000
CoexpressionAtlas	Fetal Liver, SC.STSL.FL, IgM- CD24- CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Fetal Liver, avg-2	MYH10 TRPC6 MCM7 DLK1 IL18RAP BRCA2 INTS6L STAB2 ARHGAP23 CNRIP1 GPAM EBF1 CSF3R SLC18A2 SLC25A13 UHRF1 PAM SKA3	5.18e-06	410	268	18	GSM791122_500
CoexpressionAtlas	dev gonad_e12.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000	PRR5L VSIG2 MYO10 PIEZO1 TRPC3 PCDH17 CEMIP2 CABLES1 EHD2 CLCA1 PXDN NFKB1 FES SLC23A2 INTS6L LRRC8C HSPG2 DNAJC13 STAB2 EBF3 CPA1 EBF1 TRIM3 ZC3H7A CSF1R PAK3 SPATA13	1.03e-05	847	268	27	gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_1000
CoexpressionAtlas	DevelopingKidney_e11.5_ureteric bud_emap-3844_top-relative-expression-ranked_1000	PRR5L RAP1GAP2 CARD10 BCL9 LRRC4 F3 FAAH RBM14 SLAIN1 DOP1B NRBP1 CDC42BPG DUSP9 AKNA GRIK1 GRIK2 LCK TFAP2A SAMD10 PLPP2 SLC25A13 GREB1 RIMS2 SPATA13 TPBG ABHD11	1.44e-05	813	268	26	gudmap_developingKidney_e11.5_ureteric bud_1000
CoexpressionAtlas	dev gonad_e13.5_F_DevVascOvary_Flk_top-relative-expression-ranked_1000	PRR5L VSIG2 MYO10 PIEZO1 TRPC3 PCDH17 CABLES1 EHD2 CLCA1 PXDN STARD9 FES SLC23A2 INTS6L LRRC8C HSPG2 FAT4 DNAJC13 STAB2 EBF3 EBF1 TRIM3 ATP10D ZC3H7A CSF1R SPATA13	2.09e-05	831	268	26	gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_1000
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500	TRPC6 IGSF10 FBN1 CLCA1 ALCAM FLRT2 GPAM CRY1 PCDH9	2.50e-05	122	268	9	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000	MYH10 TRPC6 DLK1 BCL9 GREB1L FBN1 CLCA1 PTPRD RBMS3 GPAM NR2F2 CRY1 VASH2 UHRF1 HAPLN3	2.73e-05	337	268	15	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000
CoexpressionAtlas	DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#3_top-relative-expression-ranked_500	PTPRD RAB3GAP2 FAT4 EBF3 ROR2 EBF1 NR2F2 THBS3 VWA5A MTR GAB1	2.84e-05	188	268	11	gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500_k3
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500	PIEZO1 DLK1 GREB1L IGSF10 FBN1 CLCA1 ALCAM CDON CPA1 GPAM NR2F2 CRY1 PAK3 HAPLN3 PCDH9	5.11e-05	356	268	15	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500
CoexpressionAtlas	dev gonad_e12.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000	TRPC3 CYP2S1 CHKA F3 CEMIP2 MEX3C GREB1L CLCA1 ATP8A1 PXDN PTPRD SYNJ2 STARD9 CNGA1 IGSF3 LRRC8C ADGRL1 CPA1 HACD2 CEMIP ENTPD5 MTR PAK3 MAPK3 G6PD GAB1	5.88e-05	884	268	26	gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#3_top-relative-expression-ranked_1000	SETD1B KDM5C PCDH17 RBM14 FLRT2 IGSF3 FAT4 EBF3 ROR2 SLC35F1 CEMIP VASH2	6.52e-05	243	268	12	gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k3
CoexpressionAtlas	DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#3_top-relative-expression-ranked_1000	PRR5L LRRC4 F3 FAAH DOP1B NRBP1 SLC35F1 TFAP2A PLPP2 SORL1	6.59e-05	171	268	10	gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k3
CoexpressionAtlas	DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000	CDS2 USP25 ADGRV1 LRRC4 EBF2 FBN1 ATP8A1 PTPRD RHOBTB1 RBMS3 RAB3GAP2 FAT4 TUT4 EBF3 ROR2 GRIK1 EBF1 NR2F2 THBS3 VWA5A PDGFD MTR PAM GAB1	7.09e-05	791	268	24	gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#2	MYO10 ADGRV1 BICD1 SLAIN1 GRIK2 ZC3H7A PAK3 RIMS2 SPATA13	9.67e-05	145	268	9	Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_500_K2
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_500	DLK1 IGSF10 FBN1 CLCA1 ALCAM GPAM NR2F2 CRY1 HAPLN3 PCDH9	1.11e-04	182	268	10	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_500
CoexpressionAtlas	FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000	USP25 DLK1 CYP2S1 ADGRV1 RETSAT PCDH17 FAAH BICD1 SLC35D1 IGSF10 SLAIN1 CDON BAHCC1 DUSP9 TMEM254 NLGN1 LCK TFAP2A ZC3H7A RSPH3 CSF1R SAMD10 VWA5A SLC25A13 GREB1 PCDH9 SPATA13	1.12e-04	973	268	27	Facebase_RNAseq_e9.5_Olfactory Placode_1000
CoexpressionAtlas	dev gonad_e12.5_F_DevVasOvary_Flk_top-relative-expression-ranked_1000	VSIG2 MYO10 PIEZO1 TRPC3 CDS2 PCDH17 CABLES1 EHD2 CLCA1 PXDN FES SLC23A2 INTS6L LRRC8C HSPG2 DNAJC13 STAB2 EBF3 EBF1 TRIM3 ZC3H7A CSF1R MAPK3 SPATA13	1.16e-04	817	268	24	gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_1000
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000	PIEZO1 TRPC6 DLK1 CHKA GREB1L IGSF10 FBN1 CLCA1 PXDN PGAP1 ALCAM CDON TUT4 ADGRL1 CPA1 GPAM NR2F2 CRY1 PAK3 UHRF1 HAPLN3 G6PD PCDH9	1.34e-04	773	268	23	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000	MYH10 TRPC6 DLK1 CHKA BCL9 MEX3C GREB1L FBN1 CLCA1 PXDN PTPRD RBMS3 PGAP1 FLRT2 CNGA1 TRPC7 CPA1 GPAM NR2F2 CRY1 VASH2 MTR UHRF1 HAPLN3	1.40e-04	827	268	24	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000
CoexpressionAtlas	DevelopingKidney_e11.5_ureteric bud_emap-3844_k-means-cluster#5_top-relative-expression-ranked_1000	RAP1GAP2 CARD10 LRRC4 SLAIN1 CDC42BPG DUSP9 GRIK1 GRIK2 TFAP2A SAMD10 PLPP2 RIMS2 ABHD11	1.49e-04	306	268	13	gudmap_developingKidney_e11.5_ureteric bud_1000_k5
CoexpressionAtlas	dev gonad_e12.5_M_SertoliCell_Sox9_top-relative-expression-ranked_500	TRPC3 CHKA MEX3C GREB1L CLCA1 ATP8A1 PXDN SYNJ2 STARD9 CNGA1 LRRC8C ADGRL1 CEMIP ENTPD5 PAK3 G6PD	1.66e-04	441	268	16	gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_500
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000	TRPC6 DLK1 IGSF10 FBN1 CLCA1 PTPRD ALCAM GPAM NR2F2 CRY1 UHRF1 HAPLN3 PCDH9	1.69e-04	310	268	13	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_500	MCM7 DLK1 INTS6L CPA1 EBF1 NR2F2	1.84e-04	66	268	6	gudmap_developingGonad_e11.5_ovary + mesonephros_k2_500
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500	CHKA CEMIP2 GREB1L CLCA1 ATP8A1 MAST4 DKC1 FLRT2 CNGA1 MGAM DNAJC13 CPA1 NR2F2 MTR PAK3	2.01e-04	403	268	15	gudmap_developingGonad_e12.5_epididymis_500
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000	TRPC6 DLK1 BCL9 GREB1L IGSF10 FBN1 CLCA1 RHOBTB1 RBMS3 ALCAM FLRT2 CDON FAT4 TRPC7 CPA1 GPAM NR2F2 ATP10D CRY1 VASH2 MTR PAM PCDH9	2.09e-04	797	268	23	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000	TRPC6 DLK1 IGSF10 FBN1 CLCA1 ALCAM GPAM NR2F2 PCDH9	2.93e-04	168	268	9	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k4_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000	DLK1 CYP2S1 ADGRV1 F3 PCDH17 FAAH CEMIP2 BICD1 SLC35D1 EBF2 IGSF10 SLAIN1 CDON EBF3 TMEM254 GRIK2 NLGN1 ZC3H7A RSPH3 CSF1R SAMD10 VWA5A ENTPD5 PAK3 RIMS2 PCDH9	3.21e-04	984	268	26	Facebase_RNAseq_e10.5_Olfactory Pit_1000
CoexpressionAtlas	Stem Cells, SC.LTSL.BM, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-2	ZBTB38 TRPC6 MCM7 BICD1 BRCA2 MMP8 BAHCC1 INTS6L ARHGAP23 TBC1D8 CSF3R SLC18A2 UHRF1 PAM SKA3	3.28e-04	422	268	15	GSM399442_500
CoexpressionAtlas	FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#2	MYO10 ADGRV1 BICD1 SLAIN1 GRIK2 NLGN1 RSPH3 PAK3 RIMS2 PCDH9 SPATA13	3.31e-04	248	268	11	Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000_K2
CoexpressionAtlas	Fetal Liver, SC.LTSL.FL, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Fetal Liver, avg-3	MYH10 TRPC6 DLK1 IL18RAP BRCA2 INTS6L ARHGAP23 CNRIP1 CSF3R SLC18A2 SLC25A13 UHRF1 PAM SKA3 GAB1	3.37e-04	423	268	15	GSM791126_500
CoexpressionAtlas	dev gonad_e13.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000	TRPC3 CHKA WNK1 F3 CEMIP2 MEX3C GREB1L CLCA1 ATP8A1 PXDN PTPRD SYNJ2 STARD9 CNGA1 LRRC8C ADGRL1 CP HACD2 CEMIP TBC1D8 ENTPD5 PAK3 G6PD GAB1	3.49e-04	880	268	24	gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_1000
CoexpressionAtlas	Progenitor-Cell-Biology-Consortium_EmbryoidBody_top-relative-expression-ranked_1000	RELN DLK1 ADGRV1 MEP1A EBF2 GREB1L PTPRD SH3RF2 WNT3A CDON FAT4 SDK2 MXRA5 DSC3 DNAH10 EBF3 ROR2 DUSP9 GRIK1 TFAP2A NSUN7 SLC6A1 TMEM132D PAX1 CSMD1 SPAG17	3.75e-04	994	268	26	PCBC_EB_1000
CoexpressionAtlas	dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#3_top-relative-expression-ranked_1000	TRPC6 IGSF10 FBN1 CLCA1 ALCAM GPAM NR2F2	4.20e-04	107	268	7	gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k3_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#5	GLT8D1 MYO10 TRPC3 ADGRV1 BICD1 ATP8A1 PTPRD SLC22A8 STARD9 SLAIN1 NPHP1 AKNA ADGRL1 GRIK2 NLGN1 SLC35F1 RSPH3 PAK3 RIMS2 PCDH9 SPATA13	4.26e-04	732	268	21	Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K5
CoexpressionAtlas	dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000	PIGN PIEZO1 CHKA CHKB CSMD3 LRRC4 MEX3C SLC35D1 GREB1L STARD9 TAFAZZIN CDON FAT4 TUT4 TRPC7 TMEM254 ADGRL1 CPA1 MED13L ATP10D SLC18A2 MTR	4.74e-04	791	268	22	gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000
CoexpressionAtlas	dev gonad_e13.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000	VSIG2 MYO10 PIEZO1 TRPC3 PCDH17 CABLES1 GREB1L CLCA1 PXDN SLC23A2 INTS6L LRRC8C HSPG2 STAB2 EBF3 CPA1 GPAM EBF1 ZC3H7A CSF1R PAK3 PCDH9 SPATA13	4.84e-04	846	268	23	gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_1000
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000	MYO10 DLK1 CYP2S1 BCL9 GREB1L IGSF10 FBN1 CLCA1 PTPRD ALCAM CNGA1 CPA1 GPAM NR2F2 CRY1 PDGFD ENTPD5 PAK3 UHRF1 HAPLN3 G6PD PCDH9	4.90e-04	793	268	22	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000	PIGN TRPC6 DLK1 CHKA WNK1 MEX3C GREB1L IGSF10 FBN1 CLCA1 PTPRD ALCAM FLRT2 SLC23A2 CDON FAT4 GPAM CRY1 MTR PAM PCDH9	4.91e-04	740	268	21	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000
CoexpressionAtlas	FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#5	GLT8D1 TRPC3 ADGRV1 GPR108 CHKB ATP8A1 PTPRD SLC22A8 PGAP1 SLAIN1 ALCAM SLC23A2 NPHP1 AKNA ADGRL1 NLGN1 SLC35F1 RSPH3 PAK3 PAM PCDH9	5.18e-04	743	268	21	Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_2500_K5
CoexpressionAtlas	DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#3_top-relative-expression-ranked_1000	CAND1 ATP8A1 PTPRD FLRT2 FAT4 EBF3 XKR8 EBF1 HACD2 NR2F2 PDGFD GAB1	5.62e-04	307	268	12	gudmap_developingKidney_e15.5_Peripheral blastema_1000_k3
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000	TRPC6 DLK1 WNK1 IGSF10 FBN1 CLCA1 ALCAM FLRT2 GPAM CRY1 PCDH9	5.78e-04	265	268	11	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000	PDPK1 MCM7 DLK1 CHKA CEMIP2 GREB1L CLCA1 ATP8A1 MAST4 DKC1 FLRT2 ZNF606 CDON INTS6L MGAM DNAJC13 CPA1 GRIK1 NR2F2 SLC18A2 GREB1 PCDH9	5.89e-04	804	268	22	gudmap_developingGonad_e12.5_ovary_1000
CoexpressionAtlas	dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000	MYH10 TRPC6 DLK1 BCL9 GREB1L FBN1 CLCA1 RBMS3 TUT4 CPA1 NR2F2 CRY1 UHRF1	6.01e-04	354	268	13	gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500	RELN MYO10 DLK1 ADGRV1 FAAH CEMIP2 BICD1 SLC22A8 SLAIN1 CABP2 GRIK2 SLC35F1 SAMD10 PAK3 RIMS2 SPATA13	6.05e-04	496	268	16	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000	MYO10 PDPK1 MCM7 CHKA CEMIP2 GREB1L CLCA1 ATP8A1 MAST4 DKC1 FLRT2 CNGA1 IGSF3 INTS6L MGAM DNAJC13 CPA1 NR2F2 MTR PAK3 HAPLN3 PCDH9	6.08e-04	806	268	22	gudmap_developingGonad_e12.5_epididymis_1000
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500	TRPC6 CHKA GREB1L IGSF10 FBN1 CLCA1 ALCAM FLRT2 FAT4 GPAM CRY1 MTR PCDH9	6.50e-04	357	268	13	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500
CoexpressionAtlas	DevelopingKidney_e15.5_Proximal Tubules_emap-28005_top-relative-expression-ranked_1000	PIGN DAO CHKB FAAH MEP1A SLC35D1 GREB1L SLC22A8 CLTC MED13 INTS6L MGAM TUT4 SLC35F1 CUBN ATP10D PITPNM1 ZC3H7A ENTPD5 SYVN1 SORL1	6.69e-04	758	268	21	gudmap_developingKidney_e15.5_Proximal Tubules_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#4	PDPK1 CYP2S1 BCL9 IGSF10 SH3RF2 CNGA1 CABP2 TUT4 DNAH10 DUSP9 TMEM254 EBF1 LCK ZC3H7A RSPH3 CSF1R SLC18A2 VWA5A MUC6	7.00e-04	655	268	19	Facebase_RNAseq_e10.5_Maxillary Arch_2500_K4
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000	PDPK1 USP25 MCM7 DLK1 CHKA CEMIP2 MAST4 RBMS3 DKC1 FLRT2 ZNF606 INTS6L MGAM DNAJC13 TUT4 EBF3 CPA1 EBF1 NR2F2 SLC18A2 PAK3 PCDH9	7.04e-04	815	268	22	gudmap_developingGonad_e11.5_ovary + mesonephros_1000
CoexpressionAtlas	Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4	F3 EHD2 IGSF10 FBN1 PXDN RBMS3 HSPG2 DSC3 EBF3 CP GPAM EBF1 NR2F2 PAM CSMD1	7.16e-04	455	268	15	GSM777055_500
CoexpressionAtlas	dev gonad_e11.5_F_ReproVasc_Flk_top-relative-expression-ranked_1000	PRR5L VSIG2 PIEZO1 TRPC3 TRPC6 WNK1 PCDH17 EHD2 CLCA1 CARD6 FLRT2 INTS6L LRRC8C HSPG2 STAB2 EBF3 CNRIP1 EBF1 LCK ZC3H7A CSF1R SLC18A2	7.27e-04	817	268	22	gudmap_dev gonad_e11.5_F_ReproVasc_Flk_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#4	MYO10 BICD1 EBF2 PGAP1 SLAIN1 NLGN1 SLC25A13 PAK3 RIMS2 TPBG	7.41e-04	231	268	10	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K4
CoexpressionAtlas	dev gonad_e11.5_F_ReproVasc_Flk_top-relative-expression-ranked_500	VSIG2 PIEZO1 TRPC3 TRPC6 PCDH17 EHD2 FLRT2 LRRC8C HSPG2 STAB2 EBF3 EBF1 CSF1R SLC18A2	7.46e-04	409	268	14	gudmap_dev gonad_e11.5_F_ReproVasc_Flk_500
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500	PIEZO1 CHKA GREB1L FBN1 CLCA1 ALCAM CNGA1 NR2F2 CRY1 PAK3 UHRF1 HAPLN3 PCDH9	7.78e-04	364	268	13	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500
CoexpressionAtlas	DevelopingKidney_e11.5_ureteric bud_emap-3844_k-means-cluster#3_top-relative-expression-ranked_500	RAP1GAP2 LRRC4 SLAIN1 GRIK1 GRIK2 LCK TFAP2A SAMD10 PLPP2	8.02e-04	193	268	9	gudmap_developingKidney_e11.5_ureteric bud_500_k3
CoexpressionAtlas	DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#2_top-relative-expression-ranked_1000	RELN ADGRV1 ATP8A1 ALCAM FAT4 ROR2 EBF1 HACD2 NR2F2 VWA5A	8.18e-04	234	268	10	gudmap_developingKidney_e15.5_Peripheral blastema_1000_k2
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500	PDPK1 DLK1 CHKA MAST4 RBMS3 STARD9 FLRT2 CDON INTS6L MGAM DNAJC13 GRIK1 NR2F2 PCDH9	8.19e-04	413	268	14	gudmap_developingGonad_e14.5_ epididymis_500
CoexpressionAtlas	facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1	GLT8D1 RAP1GAP2 BCL9 PCDH17 GREB1L IGSF10 FBN1 PTPRD SLC22A8 RBMS3 SH3RF2 CARD6 SLAIN1 ALCAM FLRT2 SEC23A ABHD14A FAT4 SDK2 CNRIP1 GRIK1 NLGN1 SLC35F1 THBS3 UBXN11 VWA5A SENP6 PAM	8.53e-04	1166	268	28	facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1
CoexpressionAtlas	dev gonad_e12.5_F_DevVasOvary_Flk_top-relative-expression-ranked_500	VSIG2 PIEZO1 TRPC3 PCDH17 CABLES1 EHD2 CLCA1 PXDN LRRC8C HSPG2 STAB2 EBF3 EBF1 CSF1R	8.58e-04	415	268	14	gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_500
CoexpressionAtlas	dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000	MYH10 TRPC6 DLK1 CHKA BCL9 F3 GREB1L FBN1 CLCA1 BRCA2 RBMS3 FLRT2 CDON FAT4 TUT4 TRPC7 CPA1 NR2F2 CRY1 MTR UHRF1 TPBG	9.07e-04	831	268	22	gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000
CoexpressionAtlas	Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5	F3 EHD2 IGSF10 FBN1 PXDN RBMS3 HSPG2 DSC3 EBF3 CP GPAM EBF1 NR2F2 PAM CSMD1	9.11e-04	466	268	15	GSM777050_500
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000	MAST4 RBMS3 STARD9 FLRT2 CDON MGAM DNAJC13 GRIK1 NR2F2 CSF1R PCDH9	9.36e-04	281	268	11	gudmap_developingGonad_e18.5_epididymis_1000_k3
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN ADGRV1 CSMD3 PTPRD USH2A DNAH5 DNAH9 MGAM FAT4 STAB2 DNAH10 SLC35F1 CSMD1 SPAG17 HYDIN	7.09e-13	184	276	15	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN ADGRV1 CSMD3 PTPRD USH2A DNAH5 DNAH9 MGAM FAT4 STAB2 DNAH10 SLC35F1 CSMD1 SPAG17 HYDIN	7.09e-13	184	276	15	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN ADGRV1 CSMD3 PTPRD USH2A DNAH5 DNAH9 MGAM FAT4 STAB2 DNAH10 SLC35F1 CSMD1 SPAG17 HYDIN	7.09e-13	184	276	15	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BAAT DLK1 ADGRV1 CSMD3 USH2A DNAH9 CNGA1 TRIM60 DNAH10 SERPINA12 RIMS2 HYDIN	4.44e-10	162	276	12	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	Children_(3_yrs)-Epithelial-basal_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TRPC6 HTR3E FCGBP WNT3A MGAM2 CP GRIK2 TFAP2A PLPP2 TPBG	2.24e-08	143	276	10	28e936c298a45f88d14f0146caf3d5a22d483cd5
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RELN TRPC3 PCDH17 GREB1L RBMS3 ALCAM GRIK1 GRIK2 NR2F2 SLC6A1 PDGFD	2.96e-08	189	276	11	f0aaf2994d319a39877d2845eaab9f166adead4e
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	F3 EBF2 GREB1L FBN1 NFATC2 RBMS3 FLRT2 EBF3 EBF1 PDGFD PAK3	3.30e-08	191	276	11	2c51850f5c559d665b8a27a12b75af9ed58dffe1
ToppCell	droplet-Lung-immune-endo-depleted-3m-Mesenchymal-adventitial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	F3 EBF2 IGSF10 FBN1 RBMS3 FLRT2 CDON HSPG2 NR2F2 THBS3 PAM	3.67e-08	193	276	11	858a186804b36d45957238d3d3eed2768b961641
ToppCell	droplet-Lung-immune-endo-depleted-3m-Mesenchymal-Adventitial_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	F3 EBF2 IGSF10 FBN1 RBMS3 FLRT2 CDON HSPG2 NR2F2 THBS3 PAM	3.67e-08	193	276	11	7865e7ec0a288249540d4cba94ae01c93e1b617c
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	IGSF10 FBN1 RBMS3 FLRT2 CDON FAT4 MXRA5 ROR2 NLGN1 EBF1 PAK3	3.67e-08	193	276	11	9ab47b360bee1d4f1092c2269e58acebe9584021
ToppCell	10x5'v1-week_17-19-Endothelial-stroma-sinusoidal_EC\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	MYO10 CARD10 PCDH17 FLRT2 HSPG2 GPR4 STAB2 EBF3 ADGRL1 NR2F2 SLC6A1	4.08e-08	195	276	11	22a481927147ec4ae9d59e6af7c87df0e9cb51e4
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TRPC6 WDR25 MAST4 RBMS3 STARD9 GPR4 FAT4 COL10A1 MXRA5 EBF1 TFAP2A	4.53e-08	197	276	11	2872a78b1be61aa1d50bc9a49294a21e922dc033
ToppCell	Tracheal-NucSeq-Stromal-Peri/Epineurial_\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CSMD3 EBF2 FBN1 RBMS3 STARD9 FLRT2 NLGN1 EBF1 NR2F2 PDGFD PAK3	5.03e-08	199	276	11	3835452e4848d7f7dd8651c17b746b271ef39688
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-CDH12-L1-2\|Neuronal / cells hierarchy compared to all cells using T-Statistic	RELN ADCY8 GREB1L RBMS3 SDK2 GRIK1 GRIK2 CUBN NR2F2 SLC6A1 SPATA13	5.29e-08	200	276	11	ead9eb579bb25fde05fc15602e3d05ab6617f7ac
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	RELN TRPC3 ADCY8 PCDH17 GREB1L RBMS3 GRIK1 GRIK2 NR2F2 SLC6A1 PDGFD	5.29e-08	200	276	11	d416a7be1a4e6232fb58a9687774da24821f1fdd
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal-GABAergic_neurons\|GW23 / Sample Type, Dataset, Time_group, and Cell type.	RELN CEMIP2 RBMS3 SLAIN1 SDK2 ARHGAP23 NR2F2 SLC6A1 PAM RIMS2 PCDH9	5.29e-08	200	276	11	c6bbd33bca86ac7a76a7ba704b3e141237d04549
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-CDH12\|Neuronal / cells hierarchy compared to all cells using T-Statistic	RELN ADCY8 GREB1L RBMS3 SDK2 GRIK1 GRIK2 CUBN NR2F2 SLC6A1 SPATA13	5.29e-08	200	276	11	c74bc12e13d002dedaaf75a2244ec111e47524e1
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR\|Neuronal / cells hierarchy compared to all cells using T-Statistic	RELN TRPC3 ADCY8 PCDH17 GREB1L RBMS3 GRIK1 GRIK2 NR2F2 SLC6A1 PDGFD	5.29e-08	200	276	11	862db57d043bdf3cb059fbfc8b29bc1eafdf64ec
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR--L1\|Neuronal / cells hierarchy compared to all cells using T-Statistic	RELN TRPC3 ADCY8 PCDH17 GREB1L RBMS3 GRIK1 GRIK2 NR2F2 SLC6A1 PDGFD	5.29e-08	200	276	11	a91345f268f13170c27309333603eb82400c9947
ToppCell	Fetal_29-31_weeks-Epithelial-club_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ADGRV1 GREB1L MAST4 SH3RF2 ALCAM DNAH5 CP TBC1D8 PLPP2 TMEM132D	7.31e-08	162	276	10	5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRV1 CSMD3 USH2A DNAH5 DNAH9 DNAH10 NLGN1 CUBN RIMS2 HYDIN	1.09e-07	169	276	10	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DCHS2 TRPC3 TRPC6 SYNJ2 HSPG2 NLGN4Y EBF1 NR2F2 SLC6A1 PAK3	1.15e-07	170	276	10	5570c0e825bca77613bf0ebde620cf744fa1cb84
ToppCell	facs-Marrow-B-cells-24m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRV1 CSMD3 ADCY8 USH2A DNAH9 CPA1 GRIK2 EBF1 CSMD1 HYDIN	1.51e-07	175	276	10	887e75fc90e59a6394d62f3c048a9cfdf6707725
ToppCell	5'-Adult-Appendix-Mesenchymal-myocytic-myofibroblast\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TRPC6 ZSWIM1 F3 PXDN RHOBTB1 RBMS3 STARD9 FLRT2 MXRA5 GPAM	1.68e-07	177	276	10	e65c0568dc5852108e9802273499bc7cf88fafab
ToppCell	COVID-19-Fibroblasts-Mesothelial_FB\|COVID-19 / group, cell type (main and fine annotations)	CPA4 FLRT2 USH2A CDON DSC3 GRIK2 NLGN1 CEMIP RIMS2	2.49e-07	141	276	9	7e6dcccb74e7ee90b69dc91b59491b84f3a713c9
ToppCell	Adult-Epithelial-club_cell-D231\|Adult / Lineage, Cell type, age group and donor	ADGRV1 MAST4 PTPRD CDON CP GRIK2 CUBN TFAP2A SLC6A1 PLPP2	2.79e-07	187	276	10	ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RELN GREB1L RBMS3 SDK2 GRIK1 GRIK2 CUBN NR2F2 SLC6A1 SPATA13	2.79e-07	187	276	10	d2ffb2f34f07b0dd5d3cb3ee0275f46ebecf4146
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	EBF2 GREB1L FBN1 RBMS3 FLRT2 CDON EBF3 EBF1 PDGFD PAK3	2.93e-07	188	276	10	ce85a56ac27a6432421dde93a1bafa8b943244b9
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RELN ADCY8 GREB1L RBMS3 SDK2 GRIK1 CUBN NR2F2 SLC6A1 SPATA13	2.93e-07	188	276	10	ee572246e0c2f41bdbc29a03edc67b831af95c09
ToppCell	Control-Fibroblasts-Adventitial_FB\|Control / group, cell type (main and fine annotations)	FBN1 NFATC2 RBMS3 FLRT2 ROR2 NLGN1 EBF1 PDGFD PAK3 GREB1	2.93e-07	188	276	10	706a26c372add839d947749f0521a0e1f5c9b0ec
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYH10 PIEZO1 UGT3A1 BICD1 GREB1L CNGA1 MXRA5 ROR2 TFAP2A MTR	3.08e-07	189	276	10	fc88c51ace7d883c01617f3f9b5fab70cc91cc09
ToppCell	Control-Lymphoid-NK\|World / Disease state, Lineage and Cell class	PRR5L RAP1GAP2 IL18RAP CEMIP2 ATP8A1 NFATC2 AKNA LCK PDGFD SORL1	3.08e-07	189	276	10	89ef0d0e66dc96cacaae6be7aacdaa884e8e66a8
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRPC6 HAPLN2 EHD2 EBF2 RBMS3 STARD9 EBF1 SLC35F1 NR2F2 SLC6A1	3.08e-07	189	276	10	fac5c291a9a87418bb0878c3d624829bdbf1f428
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	EBF2 GREB1L FBN1 RBMS3 FLRT2 CDON EBF3 ROR2 EBF1 PAK3	3.23e-07	190	276	10	efb757f11c2809e66ddb48a5c84f5433f111cb7c
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RELN TRPC3 ADCY8 PCDH17 GREB1L RBMS3 GRIK1 NR2F2 SLC6A1 PDGFD	3.39e-07	191	276	10	7b386512284dfaa0e95358b28ee82632ee965e64
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	DLK1 FLRT2 SDK2 MXRA5 DUSP9 GRIK2 PAK3 HAPLN3 PAX1 TPBG	3.39e-07	191	276	10	273c4a757292a9301de0eaeacdec91c9866be229
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RELN TRPC3 ADCY8 GREB1L RBMS3 IGSF3 GRIK1 NR2F2 SLC6A1 PDGFD	3.39e-07	191	276	10	fa50a3c7ff86e1ee07100da1ace0b0fa1b0ab26b
ToppCell	IPF-Lymphoid-NK\|World / Disease state, Lineage and Cell class	PRR5L RAP1GAP2 IL18RAP CEMIP2 ATP8A1 NFATC2 AKNA LCK PDGFD SORL1	3.39e-07	191	276	10	f206159b9d5e84cf14a65bfdc008895cec5a8081
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RELN TRPC6 ADCY8 RBMS3 ALCAM IGSF3 GRIK1 NR2F2 SLC6A1 PAM	3.39e-07	191	276	10	de54dab85db70f847de75b3b6d7667a0e13b9bfb
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	DLK1 FLRT2 CDON SDK2 MXRA5 DUSP9 CPA1 GRIK2 HAPLN3 TPBG	3.39e-07	191	276	10	f9a46956778a8773d6656340ecf5d218376d79c2
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	IGSF10 FBN1 FLRT2 FAT4 MXRA5 ROR2 NLGN1 EBF1 VASH2 PAK3	3.56e-07	192	276	10	e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81
ToppCell	droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	F3 EBF2 IGSF10 FBN1 RBMS3 FLRT2 CDON HSPG2 NR2F2 THBS3	3.56e-07	192	276	10	f9fb24457999dc9e751a099d7f995543b9330ad4
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	F3 IGSF10 FBN1 RBMS3 IGSF3 HSPG2 CP NR2F2 THBS3 PAM	3.56e-07	192	276	10	29bee88b45e23f16543ffc7cc361bc5da5d16a2b
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	F3 IGSF10 FBN1 RBMS3 IGSF3 HSPG2 CP NR2F2 THBS3 PAM	3.56e-07	192	276	10	cdc652dbfabe41b324fd85c1ed933d29fb73a49f
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ADGRV1 F3 ADCY8 CABLES1 ATP8A1 MAST4 PTPRD SLAIN1 ALCAM CSF3R	3.56e-07	192	276	10	fb2f0e897228f808d9ff734ad05e9b49dc38fa50
ToppCell	PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	STAM2 ZSWIM1 BRCA2 SYNJ2 RBM14 CARD6 ZBTB18 USP47 CSF3R SLC20A2	3.56e-07	192	276	10	c09dcc73ff9c3855a0f3d7bfa0d5c99c09a117f2
ToppCell	Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_endoneurial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CSMD3 EBF2 RBMS3 FLRT2 LILRA2 EBF3 NLGN1 EBF1 PDGFD PAK3	3.73e-07	193	276	10	549a0b750c860b615aff767ad04c9a9d20f802f0
ToppCell	COVID-19-lung-NK/NKT\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PRR5L RAP1GAP2 IL18RAP ATP8A1 NFATC2 PIK3CD AKNA LCK PDGFD SORL1	3.73e-07	193	276	10	c24b44fcc92fff42ebba6f1aff91c7aaea179e56
ToppCell	facs-Thymus-Thymus_Epithelium\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGSF10 FBN1 PTPRD RBMS3 DNAH5 DNAH10 CP NR2F2 PAM CSMD1	4.30e-07	196	276	10	6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363
ToppCell	facs-Thymus-Thymus_Epithelium-18m\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGSF10 FBN1 PTPRD RBMS3 DNAH5 DNAH10 CP NR2F2 PAM CSMD1	4.30e-07	196	276	10	c8c89e469402e11aa2a9561e859b6fd1fb66c39b
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYH10 MYO10 DLK1 IGSF10 FBN1 PTPRD RBMS3 SDK2 MXRA5 SPATA13	4.51e-07	197	276	10	fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	BICD1 FBN1 PXDN NFATC2 RBMS3 FAT4 ROR2 EBF1 ATP10D PCDH9	4.51e-07	197	276	10	85a8f1d18e0dd1d31341f5131eecd217553bf042
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	BICD1 FBN1 PXDN NFATC2 RBMS3 FAT4 ROR2 EBF1 ATP10D PCDH9	4.51e-07	197	276	10	e8e3ba791dfaa0fab35e0329a5e34376f9ee6143
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CYP2S1 F3 SH3RF2 IGSF3 DSC3 ARHGAP23 TFAP2A NR2F2 CEMIP TPBG	4.72e-07	198	276	10	fc00cb25cdc6c31b7f9d397bc9f9a8f4e9708003
ToppCell	COVID-19-COVID-19_Severe-Others-HSPC\|COVID-19_Severe / Disease, condition lineage and cell class	MYH10 SPINK2 CABLES1 EHD2 IGSF10 ARHGAP22 FBN1 HSPG2 CNRIP1 PCDH9	4.95e-07	199	276	10	25de67b6c9c8d6bb9a538e071a40ef865906c95d
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MYH10 MYO10 IGSF10 FBN1 PTPRD SDK2 CP NR2F2 PDGFD SPATA13	4.95e-07	199	276	10	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	EHD2 FBN1 PXDN RBMS3 CDON HSPG2 MXRA5 EBF1 PDGFD PAM	4.95e-07	199	276	10	40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a
ToppCell	Control-Control-Others-HSPC\|Control / Disease, condition lineage and cell class	MYH10 SPINK2 CABLES1 EHD2 IGSF10 ARHGAP22 FBN1 HSPG2 CNRIP1 PCDH9	4.95e-07	199	276	10	b71169be0d916b2ed139a3122d78bb154c71edb4
ToppCell	Tracheal\|World / Cell types per location group and 10X technology with lineage, and cell group designations	SLC12A8 FCGBP SYNJ2 SH3RF2 ROR2 CP TFAP2A PLPP2 SBF2 BPIFB2	5.18e-07	200	276	10	682960e28542a3d6c119047cd0131941932cfdea
ToppCell	Macroglial-Polydendrocytes\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CSMD3 PXDN GPR158 GRIK1 GRIK2 NLGN1 SLC35F1 TMEM132D CSMD1 RIMS2	5.18e-07	200	276	10	961858738ce35db8760c8c2e136f8369bc444ccf
ToppCell	Macroglial-Polydendrocytes-PDGFRA-\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CSMD3 PXDN GPR158 GRIK1 GRIK2 NLGN1 SLC35F1 TMEM132D CSMD1 RIMS2	5.18e-07	200	276	10	f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2
ToppCell	Macroglial-Polydendrocytes-PDGFRA--\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CSMD3 PXDN GPR158 GRIK1 GRIK2 NLGN1 SLC35F1 TMEM132D CSMD1 RIMS2	5.18e-07	200	276	10	cc3409518f8b436ea92deb955e81114b3f410ff7
ToppCell	Macroglial-Polydendrocytes-PDGFRA\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CSMD3 PXDN GPR158 GRIK1 GRIK2 NLGN1 SLC35F1 TMEM132D CSMD1 RIMS2	5.18e-07	200	276	10	c24a3099e3d96d8b72f6d05286bb355d661a0377
ToppCell	Macroglial-Polydendrocytes-PDGFRA---\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CSMD3 PXDN GPR158 GRIK1 GRIK2 NLGN1 SLC35F1 TMEM132D CSMD1 RIMS2	5.18e-07	200	276	10	4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca
ToppCell	Macroglial-Polydendrocytes-PDGFRA----L1-6\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CSMD3 PXDN GPR158 GRIK1 GRIK2 NLGN1 SLC35F1 TMEM132D CSMD1 RIMS2	5.18e-07	200	276	10	310cd53db1c137f6af74e6ae682221d7ac27310c
ToppCell	droplet-Kidney-nan-18m-Epithelial-Epcam____brush_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UGT3A1 SLC22A7 MEP1A USH2A ERICH6 ROR2 CP CSF1R ENTPD5	1.04e-06	167	276	9	ed7e785dcd25777f64e0c2596ada4f5a5ea17121
ToppCell	Club_cells-IPF_03\|World / lung cells shred on cell class, cell subclass, sample id	DCHS2 F3 FCGBP MGAM CP TFAP2A SLC6A1 PLPP2 BPIFB2	1.04e-06	167	276	9	dbdaaeb3bd9139cb008d9fe24ec031fc5628f136
ToppCell	facs-Lung-Endomucin_-18m-Myeloid-non-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAP1GAP2 FPGT KIF3B PIK3CD USP47 INTS6L NSF AKNA CSF1R	1.39e-06	173	276	9	c31076c725f4cd912c56903592a2d9356ae59f54
ToppCell	facs-Lung-Endomucin_-18m-Myeloid-Nonclassical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAP1GAP2 FPGT KIF3B PIK3CD USP47 INTS6L NSF AKNA CSF1R	1.39e-06	173	276	9	a4ed191cfdf6588b7f3672995bf0a4fe9e4b8df6
ToppCell	metastatic_Lymph_Node-Endothelial_cells-Lymphatic_ECs\|metastatic_Lymph_Node / Location, Cell class and cell subclass	RELN PCDH17 EHD2 FLRT2 HSPG2 STAB2 ARHGAP23 NR2F2 CEMIP	1.46e-06	174	276	9	d551bc29afef071adf4c9bb80345352ec33441d8
ToppCell	severe_COVID-19-HSPC\|severe_COVID-19 / disease group, cell group and cell class (v2)	SPINK2 DLK1 PCDH17 CABLES1 EHD2 ARHGAP22 FBN1 PTPRD HSPG2	1.46e-06	174	276	9	6d35bacf073537b272ff821e604c899fb9ce6a7c
ToppCell	CV-Severe-7\|Severe / Virus stimulation, Condition and Cluster	PIGN TRPC3 CEMIP2 TXNDC16 NOCT DNAJC13 NLGN4Y HACD2 PAM	1.68e-06	177	276	9	82fdd6185b368f54f03de389427cbe3071d21a99
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYO10 TRPC3 TRPC6 GPR158 STARD9 EBF1 SLC35F1 NR2F2 SLC6A1	1.76e-06	178	276	9	185b44700f06ec58b3c09c80520502166c965fd6
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-B_cells-Pre-B\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FCHO1 FAAH ABCB4 IGSF10 IGLV1-40 PIK3CD DOP1B SYVN1 PCDH9	1.76e-06	178	276	9	8545c0238d8d833a6a179872d44bfb739310ea17
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYO10 TRPC3 TRPC6 PTPRD GPR158 STARD9 EBF1 NR2F2 SLC6A1	1.85e-06	179	276	9	dc6cd46fa652b296ddbc41855f6377946d0a4cdc
ToppCell	Bronchial-NucSeq-Stromal-Pericyte-Muscle_pericyte_systemic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TRPC3 PCDH17 EBF2 CNGA1 SLC35F1 NR2F2 SLC6A1 SKA3	1.94e-06	134	276	8	bffd6ce8998368d4f486b64c220eab3a44ba147b
ToppCell	COVID-19-kidney-NK\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PRR5L RAP1GAP2 IL18RAP ATP8A1 NFATC2 PIK3CD AKNA LCK SORL1	2.02e-06	181	276	9	8906ee8a7a1616dfe8c3b5c73988416641213629
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SLC22A7 ADCY8 PTPRD RHOBTB1 SLC22A8 NLGN1 CUBN GREB1 CSMD1	2.12e-06	182	276	9	e1e58176f533092b6b974ca1ce8b02192a6e193d
ToppCell	Control-Hematopoietic_SC-HSPC\|Control / Disease group, lineage and cell class	MYH10 SPINK2 EHD2 IGSF10 ARHGAP22 FBN1 HSPG2 CNRIP1 PCDH9	2.12e-06	182	276	9	14e347c0e6444410f1948851407bb18c706569f4
ToppCell	Control-Hematopoietic_SC\|Control / Disease group, lineage and cell class	MYH10 SPINK2 EHD2 IGSF10 ARHGAP22 FBN1 HSPG2 CNRIP1 PCDH9	2.12e-06	182	276	9	43243c6bae2ac7fa3fd1f193a17f61ee4d938ea9
ToppCell	facs-Liver-Hepatocytes-24m-Epithelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UGT3A1 RETSAT FAAH ABCB4 SLC35D1 PTPRD SLC27A5 GPAM SLC20A2	2.12e-06	182	276	9	77ab860e2add49dad0c1ffbfc64278ad499dfbd5
ToppCell	facs-Liver-Hepatocytes-24m-Epithelial-hepatocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UGT3A1 RETSAT FAAH ABCB4 SLC35D1 PTPRD SLC27A5 GPAM SLC20A2	2.12e-06	182	276	9	4921c7d5687cc79f896b39753bb621d7e3d2972f
ToppCell	facs-Liver-Hepatocytes-24m-Epithelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UGT3A1 RETSAT FAAH ABCB4 SLC35D1 PTPRD SLC27A5 GPAM SLC20A2	2.12e-06	182	276	9	770ce9f3f4538d0181a0181543841bc964c68274
ToppCell	PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CHKA F3 ARHGAP22 SH3RF2 WNT3A ALCAM HSPG2 TRIM3 THBS3	2.12e-06	182	276	9	573771130247e869e4e58f22d4a1cb31989635cf
ToppCell	PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CHKA F3 ARHGAP22 SH3RF2 WNT3A ALCAM HSPG2 TRIM3 THBS3	2.12e-06	182	276	9	6cfaa2b3b3974c13b01c943f4adb70768dcc35e4
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SLC22A7 ADCY8 PTPRD RHOBTB1 SLC22A8 NLGN1 CUBN GREB1 CSMD1	2.12e-06	182	276	9	57bb5a2da976464ba7c4460106bd9f692008ebd9
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 ADGRV1 SLC22A7 ADCY8 USH2A MGAM CUBN GREB1 CSMD1	2.21e-06	183	276	9	d73cac83cde82665f110baad7cf28db75f9ffe52
ToppCell	facs-Liver-Hepatocytes-24m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RETSAT FAAH ABCB4 SLC35D1 PTPRD CLUH SLC27A5 GPAM SLC20A2	2.21e-06	183	276	9	d0721c6aa426953a520d40e976b6e65aa7ca65e8
ToppCell	droplet-Spleen-nan-21m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH10 ABCB4 CLCA1 IGSF3 NPHP1 ARHGAP23 UHRF1 SKA3 CDC20	2.42e-06	185	276	9	239cc5184825b3cc98638d4aec0a1de8e508d76c
ToppCell	COVID-19-Fibroblasts-Adventitial_FB\|COVID-19 / group, cell type (main and fine annotations)	FBN1 RBMS3 FLRT2 ROR2 NLGN1 EBF1 CEMIP PDGFD GREB1	2.42e-06	185	276	9	a5aebf2b9b05b550d021272731d68af9a6b1229d
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L3-4_RORB_RPS3P6\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	VSIG2 TRPC3 ADGRV1 USH2A FAT4 TRPC7 ROR2 GAB1 TPBG	2.42e-06	185	276	9	10da5c2a92bfb3248d3f6f94a0933996326cf590
ToppCell	droplet-Liver-LIVER_HEP-30m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VSIG2 CEMIP2 IGSF10 CLCA1 SYNJ2 HSPG2 ZNF354A NR2F2 MUC6	2.42e-06	185	276	9	bdd2e6cb20294b39a9d856004bf57ba69cf877e2
ToppCell	droplet-Kidney-nan-18m-Epithelial-Epcam____podocyte-3\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FCGBP RBMS3 ALCAM DNAH5 DNAH10 CP SLC18A2 PAK3 HYDIN	2.53e-06	186	276	9	29c79b5a29907d4f3f87ad2ca04840c0f15b7d4e
ToppCell	(0)_MSCs\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	FBN1 PTPRD IGSF3 EBF3 CP EBF1 SERPINA12 CNNM1 CSMD1	2.53e-06	186	276	9	a832c1e0035bcd559722eccf262c145deb3494c7
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	RELN PTPRD ALCAM FLRT2 CDON NLGN1 EBF1 PDGFD PCDH9	2.53e-06	186	276	9	8915436d09775f2828a7678af203b1082b36e21c
ToppCell	(0)_MSCs-(00)_Lepr-MSC\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	FBN1 PTPRD IGSF3 EBF3 CP EBF1 SERPINA12 CNNM1 CSMD1	2.53e-06	186	276	9	f0d156167d7cc2cd8a76e5a364233e9f2170bc01
ToppCell	10x5'v1-week_12-13-Endothelial-stroma-sinusoidal_EC\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	CARD10 PCDH17 FLRT2 HSPG2 GPR4 STAB2 NR2F2 HAPLN3 SERPINA5	2.53e-06	186	276	9	e8ead5634686ebaa6a230eea69795d923ce9939d
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RELN TRPC3 GREB1L RBMS3 GRIK1 GRIK2 NR2F2 SLC6A1 PDGFD	2.53e-06	186	276	9	310d16f4e5cffee3ea6d7635508c513a3b92131e
ToppCell	3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor-Neuroblast\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ADGRV1 PCDH17 CEMIP2 RBMS3 ZBTB18 EBF3 GRIK2 SLC35F1 PCDH9	2.64e-06	187	276	9	dfc2b95d70daf533bc0cc4ce78af9f65dd75a25b
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRPC6 EHD2 EBF2 RBMS3 STARD9 EBF1 SLC35F1 NR2F2 SLC6A1	2.64e-06	187	276	9	48bfdb3504c3fefe5db3abac4b790c369680ab4e
Drug	S-(+)-ibuprofen [51146-56-6]; Up 200; 19.4uM; MCF7; HT_HG-U133A	PDPK1 WDR25 BCL9 WNK1 F3 FCHO1 RRP12 SLC23A2 TAFAZZIN KYAT1 SLC20A2 GREB1 DHX34	8.83e-07	200	271	13	5311_UP
Drug	pentafluoroethyl	F3 CP ENTPD5 G6PD	1.32e-06	8	271	4	CID000137907
Drug	SQ 14,603	CPA4 MMP8 CPA5 CPA1	1.32e-06	8	271	4	CID000194327
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A	SLC12A8 RRP12 STAB2 DSC3 MAP3K8 NLGN1 TFAP2A NR2F2 CNNM1 ENTPD5 SENP6 PAM	3.90e-06	194	271	12	2672_DN
Drug	Naringenine [480-41-1]; Down 200; 14.6uM; MCF7; HT_HG-U133A	SLC35D1 GREB1L MAST4 PIK3CD FLRT2 DSC3 ATP10D THBS3 CSF1R RIMS2 MUC6 GAB1	3.90e-06	194	271	12	4422_DN
Drug	Metrizamide [31112-62-6]; Down 200; 5uM; MCF7; HT_HG-U133A	WDR25 FCHO1 FAAH PXDN SYNJ2 SLC23A2 ABHD14A TRIM3 THBS3 VASH2 GREB1 DHX34	4.34e-06	196	271	12	3255_DN
Drug	Riluzole hydrochloride; Up 200; 14.8uM; HL60; HT_HG-U133A	MYO10 RAP1GAP2 WNK1 CLCA1 TECPR2 SYNJ2 FLRT2 DMWD LILRA2 MAP3K8 ADGRL1 VWA5A	4.57e-06	197	271	12	2334_UP
Drug	Methylhydantoin-5-(L) [40856-73-3]; Up 200; 35uM; HL60; HT_HG-U133A	RELN TRPC3 SLC12A8 SLC22A7 EHD2 DMWD COL10A1 TRPC7 GRIK2 NLGN1 LCK NR2F2	4.57e-06	197	271	12	3040_UP
Drug	Halcinonide [3093-35-4]; Down 200; 8.8uM; MCF7; HT_HG-U133A	KDM5C F3 FAAH MAST4 TAFAZZIN BAHCC1 ABHD14A HSPG2 DSC3 KYAT1 TRIM3 GREB1	4.82e-06	198	271	12	6040_DN
Drug	Thioperamide maleate [106243-16-7]; Down 200; 9.8uM; MCF7; HT_HG-U133A	SETD1B SLC12A8 SLC22A7 SLC35D1 SYNJ2 RAB3GAP2 ZNF606 STAB2 TRIM3 CSF1R VASH2 GAB1	5.07e-06	199	271	12	5635_DN
Drug	hydroxyl radicals	CPA4 BAAT USP25 DAO CYP2S1 ABCB4 GANAB KIF3B ATP8A1 PTPRD SYNJ2 NFKB1 PGAP1 CLTC SLC27A5 USP47 MGAM CPA5 NSF PLA2G3 DUSP9 CP CPA1 LCK ATP10D COG8 PLPP2 SLC18A2 ENTPD5 MTR PAM MAPK3 SPAG17 G6PD GAB1	1.09e-05	1341	271	35	CID000000961
Drug	ochratoxin alpha	CPA4 CPA5 CPA1 KYAT1	1.29e-05	13	271	4	CID000107911
Drug	Thapsigargin	MYH10 TRPC3 TRPC6 MCM7 DLK1 WDR25 NUDT8 GANAB ATP8A1 PTPRD TM9SF2 BRCA2 NFATC2 RAB3GAP2 PGAP1 CLTC CPSF1 ALCAM FLRT2 SEC23A LRRC8C EP400 COPG1 RNASEH2A AKNA EBF1 NDUFA11 CRY1 PITPNM1 SLC25A13 ENTPD5 UHRF1 MAPK3 SYVN1 CDC20	1.31e-05	1353	271	35	ctd:D019284
Drug	N-Q-I	CPA4 CLTC CP CPA1	1.79e-05	14	271	4	CID015942689
Drug	IC261	DLK1 CHKA ABCB4 DNAH5 DNAH9 DNAH10 GRIK2 KYAT1	1.95e-05	96	271	8	CID000003674
Drug	2-propylpentanoic acid; Up 200; 50uM; HL60; HT_HG-U133A	CLCA1 FAT4 DSC3 PLA2G3 GRIK2 NR2F2 THBS3 RIMS2 DHX34 MUC6 SERPINA5	2.13e-05	193	271	11	2682_UP
Drug	radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A	KDM5C SLC35D1 MAST4 SYNJ2 ALCAM TAFAZZIN BAHCC1 ADGRL1 PITPNM1 THBS3 VWA5A	2.35e-05	195	271	11	5579_DN
Drug	Nimesulide [51803-78-2]; Down 200; 13uM; PC3; HT_HG-U133A	PDPK1 WNK1 F3 MAST4 DMWD SLC23A2 TAFAZZIN ADGRL1 TFAP2A THBS3 DHX34	2.46e-05	196	271	11	2112_DN
Drug	Napelline [5008-52-6]; Up 200; 11.2uM; MCF7; HT_HG-U133A	FBN1 CLCA1 MAST4 FLRT2 ZBTB18 KRT2 STAB2 DSC3 ADGRL1 CEMIP PITPNM1	2.46e-05	196	271	11	6824_UP
Drug	nordihydroguaiaretic acid; Up 200; 1uM; MCF7; HT_HG-U133A	PDPK1 BAAT PCDH17 GREB1L TAFAZZIN CABP2 MXRA5 DUSP9 CPA1 CSF1R RIMS2	2.46e-05	196	271	11	5583_UP
Drug	Clobetasol propionate [25122-46-7]; Down 200; 8.6uM; MCF7; HT_HG-U133A	SLC12A8 FAAH MAST4 ALCAM TAFAZZIN HSPG2 TMEM254 TRIM3 CEMIP SERPINA5 GAB1	2.58e-05	197	271	11	6095_DN
Drug	Cloxacillin sodium salt [642-78-4]; Down 200; 8.8uM; PC3; HT_HG-U133A	PTBP1 F3 BICD1 BRCA2 SYNJ2 SLC23A2 CDON FPGS ADGRL1 CNNM1 DHX34	2.58e-05	197	271	11	2126_DN
Drug	Evoxine [522-11-2]; Down 200; 11.6uM; PC3; HT_HG-U133A	PIGN F3 CEMIP2 BICD1 RHOBTB1 SYNJ2 SLC23A2 SLC27A5 CDON KYAT1 PAK3	2.83e-05	199	271	11	7380_DN
Drug	Cefmetazole sodium salt [56796-39-5]; Down 200; 8.2uM; MCF7; HT_HG-U133A	MYO10 WNK1 F3 ZNF606 HSPG2 KYAT1 CSF1R VWA5A RIMS2 DHX34 SERPINA5	2.83e-05	199	271	11	6086_DN
Drug	TTNPB; Down 200; 0.1uM; MCF7; HG-U133A	MYH10 MYO10 IL18RAP BICD1 DMWD STAB2 TRIM3 GREB1 MAPK3 DHX34 PCDH9	2.83e-05	199	271	11	223_DN
Drug	Atropine sulfate monohydrate [5908-99-6]; Down 200; 5.8uM; MCF7; HT_HG-U133A	KDM5C CEMIP2 MAST4 SLC23A2 TAFAZZIN DOP1B FPGS ADGRL1 KYAT1 TRIM3 GREB1	2.83e-05	199	271	11	7219_DN
Drug	Picotamide monohydrate [80530-63-8]; Up 200; 10.2uM; MCF7; HT_HG-U133A	RELN FBN1 PIK3CD CABP2 COL10A1 DSC3 DUSP9 VWA5A VASH2 NUP188 DHX34	2.96e-05	200	271	11	6787_UP
Drug	BAPACPL	CPA4 CPA5 CPA1	3.25e-05	6	271	3	CID006439357
Drug	BACPL	CPA4 CPA5 CPA1	3.25e-05	6	271	3	CID006439356
Drug	2-benzyl-4-oxobutanoic acid	CPA4 CPA5 CPA1	3.25e-05	6	271	3	CID000124534
Drug	2-benzyl-3-iodo-propanoic acid	CPA4 CPA5 CPA1	3.25e-05	6	271	3	CID000001542
Drug	S)-alpha-benzylmalic acid	CPA4 CPA5 CPA1	3.25e-05	6	271	3	CID003050318
Drug	5-benzamido-2-benzyl-4-oxopentanoic acid	CPA4 CPA5 CPA1	3.25e-05	6	271	3	CID000127893
Drug	AC1L9R5V	CPA4 CPA5 CPA1	3.25e-05	6	271	3	CID000453753
Drug	3,10-dimethyl-5-deazaisoalloxazine	CPA4 CPA5 CPA1	3.25e-05	6	271	3	CID000100264
Drug	Dakh peptide	CPA4 CPA5 CPA1	3.25e-05	6	271	3	CID003083120
Drug	ochratoxin B methyl ester	CPA4 CPA5 CPA1	3.25e-05	6	271	3	CID000609664
Drug	benzoylglycylphenyllactate	CPA4 CPA5 CPA1	3.25e-05	6	271	3	CID000151136
Drug	2-benzyl-3-phosphonopropionic acid	CPA4 CPA5 CPA1	3.25e-05	6	271	3	CID000127415
Drug	ClCH2CO-DL-(N-OH)Leu-OCH3	CPA4 CPA5 CPA1	3.25e-05	6	271	3	CID000191880
Drug	2-ethyl-2-methylsuccinic acid	CPA4 CPA5 CPA1	3.25e-05	6	271	3	CID000097776
Drug	AC1L5GYK	CPA4 CPA5 CPA1	3.25e-05	6	271	3	CID000275083
Drug	1-Naphthylisothiocyanate	GLT8D1 BAAT DAO CHKA F3 SLC22A7 CEMIP2 ABCB4 FBN1 PXDN PTPRD SLC22A8 NFKB1 NOCT SLC27A5 MAP3K8 CP GPAM CSF1R PLPP2 SLC25A13 PAM MAPK3 SYVN1 SERPINA5	4.81e-05	871	271	25	ctd:D015058
Drug	CPAs	CPA4 ABCB4 CPA5 CPA1 SERPINA5	5.58e-05	35	271	5	CID000016770
Drug	SQ24798	CPA4 CPA5 CPA1	5.63e-05	7	271	3	CID000194328
Drug	beta-dolabrin	CPA4 CPA5 CPA1	5.63e-05	7	271	3	CID000188981
Drug	gamma-thujaplicin	CPA4 CPA5 CPA1	5.63e-05	7	271	3	CID000012649
Drug	Indocyanine Green	SLC22A7 ABCB4 SLC22A8	5.63e-05	7	271	3	ctd:D007208
Drug	hippurylglycine	CPA4 CPA5 CPA1	5.63e-05	7	271	3	CID000096770
Drug	belinostat	RELN ZBTB38 SPINK2 PIEZO1 UGT3A1 CARD10 MCM7 CABLES1 FBN1 SYNJ2 WNT3A NFKB1 NOCT MGAM MAP3K8 DUSP9 AKNA GRIK1 TFAP2A NSUN7 VASH2	6.85e-05	678	271	21	ctd:C487081
Drug	ICI 182,780; Down 200; 0.01uM; MCF7; HT_HG-U133A	KDM5C WNK1 BICD1 RHOBTB1 SYNJ2 DKC1 MED13L SENP6 GREB1 TPBG	6.87e-05	182	271	10	1663_DN
Drug	Frie Mao 1-43	TRPC6 ADGRV1 CLTC NSF GRIK1 SLC18A2	8.63e-05	61	271	6	CID002733618
Drug	Boc-ca-phe	CPA4 CPA5 CPA1	8.94e-05	8	271	3	CID005487215
Drug	AC1NUP4F	CPA4 CPA5 CPA1	8.94e-05	8	271	3	CID005487101
Drug	hippuryl-L-phenylalanine	CPA4 CP CPA1	8.94e-05	8	271	3	CID000098154
Drug	Z-ca-gly-phe	CPA4 CPA5 CPA1	8.94e-05	8	271	3	CID000195338
Drug	Thioguanosine [85-31-4]; Up 200; 12.6uM; MCF7; HT_HG-U133A	PIGN BAAT SLC22A7 MAST4 PGAP1 TAFAZZIN NPHP1 HSPG2 RIMS2 PCDH9	9.83e-05	190	271	10	2619_UP
Drug	Rpch	CPA4 CPA5 CPA1 TMEM132D	1.00e-04	21	271	4	CID000123998
Drug	yellow prussiate	COPG1 NSF ENTPD5 PAM	1.00e-04	21	271	4	CID000161067
Drug	Methapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; PC3; HT_HG-U133A	ZBTB38 WNK1 MAST4 SYNJ2 RRP12 CNGA1 TAFAZZIN NR2F2 EDEM3 DHX34	1.03e-04	191	271	10	6644_DN
Drug	Deltaline [6836-11-9]; Down 200; 7.8uM; MCF7; HT_HG-U133A	WDR25 SLC35D1 GREB1L MAST4 CPSF1 ALCAM SEC23A DUSP9 CSF1R PCDH9	1.07e-04	192	271	10	3925_DN
Drug	Betahistine mesylate [54856-23-4]; Down 200; 17.2uM; MCF7; HT_HG-U133A	SLC12A8 WDR25 BCL9 SYNJ2 RRP12 TAFAZZIN GEMIN2 ADGRL1 VASH2 SENP6	1.12e-04	193	271	10	2833_DN
Drug	Estropipate [7280-37-7]; Down 200; 9.2uM; MCF7; HT_HG-U133A	SLC12A8 FAAH ALCAM ZNF606 GREB1 NUP188 RIMS2 PCDH9 SERPINA5 GAB1	1.17e-04	194	271	10	6068_DN
Drug	ionomycin calcium salt; Up 200; 2uM; MCF7; HT_HG-U133A_EA	SLC12A8 WDR25 F3 RRP12 TRPC7 MAP3K8 PLA2G3 PITPNM1 VASH2 RIMS2	1.22e-04	195	271	10	871_UP
Drug	CP-690334-01 [459212-38-5]; Down 200; 1uM; MCF7; HT_HG-U133A	PIGN SLC12A8 WNK1 SYNJ2 PIK3CD STAB2 PLA2G3 TRIM3 VWA5A SERPINA5	1.22e-04	195	271	10	3909_DN
Drug	Clozapine [5786-21-0]; Up 200; 12.2uM; MCF7; HT_HG-U133A	TECPR2 SYNJ2 RAB3GAP2 FLRT2 ZBTB18 DOP1B HSPG2 PLA2G3 THBS3 RIMS2	1.22e-04	195	271	10	5265_UP
Drug	Tacrine hydrochloride hydrate [1684-40-8]; Up 200; 15.8uM; MCF7; HT_HG-U133A	SETD1B CHKA WNK1 F3 PGAP1 SLC23A2 SEC23A SLC27A5 DOP1B DHX34	1.22e-04	195	271	10	5297_UP
Drug	Dicumarol [66-76-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A	CARD10 SLC12A8 SLC35D1 GREB1L CDON HSPG2 TUT4 TRIM3 DHX34 SERPINA5	1.22e-04	195	271	10	3941_DN
Drug	Sulfamethoxazole [723-46-6]; Up 200; 15.8uM; HL60; HT_HG-U133A	ZBTB38 WNK1 BRCA2 TECPR2 SYNJ2 SLC23A2 CABP2 ZNF354A CNNM1 TPBG	1.27e-04	196	271	10	2335_UP
Drug	Sulfaquinoxaline sodium salt [967-80-6]; Up 200; 12.4uM; HL60; HT_HG-U133A	CDS2 TRPC6 PCDH17 FBN1 NOCT DMWD MXRA5 LCK TRIM3 CNNM1	1.27e-04	196	271	10	2528_UP
Drug	Phenazopyridine hydrochloride [136-40-3]; Down 200; 16uM; HL60; HT_HG-U133A	STAM2 CDS2 BICD1 PIK3CD FLRT2 CDON CABP2 TUT4 NR2F2 PAM	1.27e-04	196	271	10	2537_DN
Drug	Methylprednisolone, 6-alpha [83-43-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A	SYNJ2 ALCAM SLC23A2 HSPG2 CNNM1 VASH2 ENTPD5 PAM DHX34 GAB1	1.27e-04	196	271	10	3183_DN
Drug	Sulfadimethoxine [122-11-2]; Up 200; 12.8uM; MCF7; HT_HG-U133A	SETD1B WNK1 SLC35D1 FBN1 ALCAM ZNF606 SLC23A2 THBS3 GREB1 SERPINA5	1.27e-04	196	271	10	4724_UP
Drug	Proxyphylline [603-00-9]; Up 200; 16.8uM; HL60; HT_HG-U133A	MYH10 FAAH SLC35D1 PIK3CD SLC23A2 CDON COL10A1 TFAP2A VASH2 RIMS2	1.27e-04	196	271	10	3115_UP
Drug	Sulfaguanidine [57-67-0]; Up 200; 18.6uM; PC3; HT_HG-U133A	DCHS2 TRPC6 HAPLN2 PCDH17 EBF2 FES TRPC7 MAP3K8 PKD2L2 DHX34	1.27e-04	196	271	10	4257_UP
Drug	Ethambutol dihydrochloride [1070-11-7]; Up 200; 14.4uM; MCF7; HT_HG-U133A	SLC22A7 TECPR2 RAB3GAP2 DOP1B HSPG2 ADGRL1 VWA5A RIMS2 DHX34 GAB1	1.32e-04	197	271	10	4120_UP
Drug	estradiol, USP; Down 200; 0.1uM; PC3; HT_HG-U133A	F3 SLC35D1 ATP8A1 BRCA2 SLC23A2 ADGRL1 EDEM3 THBS3 SLC20A2 VASH2	1.32e-04	197	271	10	1208_DN
Drug	PF-00875133-00 [351322-64-0]; Down 200; 10uM; MCF7; HT_HG-U133A	STAM2 DLK1 ABCB4 TECPR2 CDON TMEM254 PRX CSF1R NUP188 PCDH9	1.32e-04	197	271	10	5923_DN
Drug	Hesperidin [520-26-3]; Up 200; 6.6uM; PC3; HT_HG-U133A	PRR5L SLC22A7 ABCB4 ARHGAP22 ATP8A1 TRIM3 PRX VWA5A DHX34 MUC6	1.32e-04	197	271	10	6714_UP
Drug	Propantheline bromide [50-34-0]; Down 200; 9uM; PC3; HT_HG-U133A	MAST4 BRCA2 TECPR2 SYNJ2 ZBTB18 DUSP9 CNNM1 CSF1R PAK3 DHX34	1.32e-04	197	271	10	4214_DN
Drug	Ioxaglic acid [59017-64-0]; Down 200; 3.2uM; MCF7; HT_HG-U133A	SETD1B BICD1 SLC35D1 MAST4 TECPR2 ZNF606 TAFAZZIN THBS3 VASH2 GREB1	1.32e-04	197	271	10	3528_DN
Drug	Suramin sodium salt; Up 200; 10uM; PC3; HT_HG-U133A	F3 CEMIP2 TECPR2 RRP12 DOP1B BAHCC1 TUT4 KYAT1 CNNM1 THBS3	1.32e-04	197	271	10	7529_UP
Drug	iodoacetic acid	NIT2 TAFAZZIN MGAM RNASEH2A NSF GRIK1 G6PD	1.33e-04	94	271	7	CID000005239
Drug	MTX-Ala	CPA4 CPA5 CPA1	1.33e-04	9	271	3	CID005489429
Drug	Muracein A	CPA4 CPA5 CPA1	1.33e-04	9	271	3	CID005491013
Drug	cuminaldehyde	DNAH5 MGAM PAM	1.33e-04	9	271	3	CID000000326
Drug	Tiletamine hydrochloride; Up 200; 15.4uM; MCF7; HT_HG-U133A	EHD2 RAB3GAP2 PGAP1 TAFAZZIN BAHCC1 DSC3 TMEM254 ADGRL1 VWA5A RIMS2	1.38e-04	198	271	10	6013_UP
Drug	(R) -Naproxen sodium salt [26159-34-2]; Down 200; 15.8uM; MCF7; HT_HG-U133A	PIGN SYNJ2 ALCAM BAHCC1 STAB2 DUSP9 TRIM3 PDGFD NUP188 RIMS2	1.38e-04	198	271	10	6096_DN
Drug	Chlorthalidone [77-36-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A	SLC12A8 MAST4 PGAP1 CABP2 COL10A1 STAB2 NLGN1 PRX PITPNM1 GAB1	1.38e-04	198	271	10	6800_UP
Drug	Trimethoprim [738-70-5]; Up 200; 13.8uM; HL60; HT_HG-U133A	CDS2 WNK1 IL18RAP TECPR2 SYNJ2 ZNF606 LILRA2 GRIK2 NR2F2 THBS3	1.38e-04	198	271	10	2345_UP
Drug	0225151-0000 [351320-15-5]; Down 200; 10uM; MCF7; HT_HG-U133A	RELN SETD1B NOCT DOP1B STAB2 TRIM3 CEMIP PITPNM1 EDEM3 NUP188	1.38e-04	198	271	10	6384_DN
Drug	Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A	CDS2 SLC35D1 GANAB PXDN TM9SF2 IGSF3 EDEM3 SLC20A2 SORL1	1.39e-04	161	271	9	3556_DN
Drug	B18C6	CP TMEM132D	1.41e-04	2	271	2	CID000585779
Drug	5-nitro-6,7,8,9-tetrahydrobenzo(G)indole-2,3-dione-3-oxime	GRIK1 GRIK2	1.41e-04	2	271	2	ctd:C084273
Drug	Dosulepin hydrochloride [897-15-4]; Down 200; 12uM; PC3; HT_HG-U133A	PIGN STAM2 SLC12A8 DLK1 BAHCC1 FPGS TFAP2A NR2F2 CEMIP PITPNM1	1.44e-04	199	271	10	7284_DN
Drug	Trichlorfon [52-68-6]; Up 200; 15.6uM; PC3; HT_HG-U133A	STAM2 ZBTB38 GREB1L PGAP1 TAFAZZIN FAT4 GEMIN2 DUSP9 GRIK2 MAPK3	1.44e-04	199	271	10	1797_UP
Drug	Dapsone [80-08-0]; Up 200; 16.2uM; PC3; HT_HG-U133A	SLC22A7 EBF2 CPSF1 MGAM GRIK1 NLGN1 TRIM3 SLC6A1 VWA5A DHX34	1.44e-04	199	271	10	5078_UP
Drug	Azathioprine [446-86-6]; Down 200; 14.4uM; PC3; HG-U133A	SETD1B MAST4 RBMS3 CPSF1 NOCT TAFAZZIN GPR4 FPGS PITPNM1 NUP188	1.44e-04	199	271	10	1945_DN
Drug	betaine	CHKA WNK1 NFKB1 SLC23A2 CDON CPA1 SLC6A1 SLC18A2 MTR G6PD	1.50e-04	200	271	10	CID000000247
Drug	Laudanosine (R,S) [1699-51-0]; Up 200; 11.2uM; HL60; HG-U133A	CDS2 WNK1 RBMS3 BAHCC1 KRT2 STAB2 ADGRL1 CUBN NR2F2 ZC3H7A	1.50e-04	200	271	10	1741_UP
Disease	myeloid white cell count	SETD1B SPINK2 PIEZO1 TRPC6 DLK1 CYP2S1 BCL9 FCHO1 SLC35D1 NFKB1 FES ZNF398 DNAJC13 DNAH10 ARHGAP23 PLA2G3 GPAM EBF1 PRX TBC1D8 CSF3R SBF2 SPAG17 SORL1	4.98e-06	937	266	24	EFO_0007988
Disease	Bipolar Disorder	RELN TRPC3 DAO BCL9 ADCY8 BRCA2 STARD9 TRPC7 GRIK1 GRIK2 NLGN1 CRY1 SLC18A2 MTR CSMD1 G6PD	7.99e-06	477	266	16	C0005586
Disease	aspartate aminotransferase measurement	PDPK1 PIEZO1 PTBP1 CHKA CHKB IL18RAP ABCB4 DHX15 PTPRD RBMS3 DNAJC13 OR4C11 AKNA GPAM PDPK2P CUBN TBC1D8 CNNM1 CSF1R MROH6 TMEM132D ENTPD5 CSMD1	8.80e-06	904	266	23	EFO_0004736
Disease	schizophrenia (implicated_via_orthology)	RELN CSMD3 KIF3B SLC6A1 CSMD1 RIMS2	3.48e-05	68	266	6	DOID:5419 (implicated_via_orthology)
Disease	Primary Ciliary Dyskinesia	DNAH5 DNAH9 RSPH3 GAS2L2 HYDIN	6.45e-05	47	266	5	C4551720
Disease	sensory perception of smell	DHX15 STAB2 NSF PCDH9	1.28e-04	29	266	4	GO_0007608
Disease	serum metabolite measurement	MYH10 UGT3A1 RAP1GAP2 BCL9 FAAH ABCB4 EBF2 OR10AG1 TXNDC16 ALCAM NOCT NRBP1 CDC42BPG GPAM GRIK2 TFAP2A KYAT1 ATP10D CSF1R SLC18A2 CSMD1	1.48e-04	945	266	21	EFO_0005653
Disease	nicotine dependence (implicated_via_orthology)	TRPC3 TRPC6 TRPC7	1.50e-04	12	266	3	DOID:0050742 (implicated_via_orthology)
Disease	bitter alcoholic beverage consumption measurement	RELN PTPRD BAHCC1 MGAM POLR2B CSMD1 SORL1	2.12e-04	133	266	7	EFO_0010092
Disease	cortical surface area measurement	CPA4 DCHS2 RELN MYH10 SPINK2 SLC12A8 ADGRV1 STOX1 RETSAT FBN1 MAST4 PIK3CD RAB3GAP2 NFKB1 FES ALCAM ZBTB18 DNAJC13 NSF EBF1 MED13L NR2F2 PDGFD UHRF1 PAM SPAG17	2.28e-04	1345	266	26	EFO_0010736
Disease	neuroligin-1 measurement	STAB2 NLGN1	2.41e-04	3	266	2	EFO_0802802
Disease	response to 5-fluorouracil, response to cyclophosphamide, chemotherapy-induced alopecia, response to doxorubicin	VSIG2 BCL9 CSMD1	2.45e-04	14	266	3	EFO_0005400, GO_0036275, GO_1902518, GO_1902520
Disease	Kartagener Syndrome	DNAH9 RSPH3 GAS2L2 HYDIN	2.71e-04	35	266	4	C0022521
Disease	Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus	DNAH9 RSPH3 GAS2L2 HYDIN	2.71e-04	35	266	4	C4551906
Disease	Polynesian Bronchiectasis	DNAH9 RSPH3 GAS2L2 HYDIN	2.71e-04	35	266	4	C4317124
Disease	FEV/FEC ratio	DCHS2 SPINK2 MCM7 ADCY8 CEMIP2 DHX15 FBN1 FCGBP KIF3B RBMS3 DNAH5 CDON HSPG2 MGAM CPA1 DEFB135 NR2F2 THBS3 SBF2 MAPK3 CSMD1 ABHD12 SPATA13 SORL1	3.41e-04	1228	266	24	EFO_0004713
Disease	vision disorder	MYH10 F3 PXDN	3.72e-04	16	266	3	MONDO_0021084
Disease	respiratory symptom change measurement, response to placebo	ADCY8 EBF2 DHX15	4.49e-04	17	266	3	EFO_0008344, EFO_0010068
Disease	intrahepatic cholestasis (implicated_via_orthology)	ABCB4 SLC25A13	4.80e-04	4	266	2	DOID:1852 (implicated_via_orthology)
Disease	metabolite measurement	UGT3A1 BAAT ZSWIM1 FAAH NIT2 ARHGAP22 ALCAM ABHD1 GPAM KYAT1 ATP10D CSMD1 G6PD SORL1	6.17e-04	560	266	14	EFO_0004725
Disease	lifestyle measurement, alcohol consumption measurement	ADCY8 CEMIP2 GRIK2 EBF1 SLC6A1 DHX34	6.29e-04	115	266	6	EFO_0007878, EFO_0010724
Disease	Disproportionate short stature	SLC35D1 FBN1 HSPG2 COL10A1 ROR2	6.67e-04	77	266	5	C0878659
Disease	disorder of pharynx	SLC12A8 NFKB1 GAS2L2 SLC20A2	7.82e-04	46	266	4	MONDO_0020592
Disease	homocysteine measurement	DCHS2 CUBN MTR CSMD1	7.82e-04	46	266	4	EFO_0004578
Disease	holoprosencephaly (implicated_via_orthology)	PIGN PGAP1	7.95e-04	5	266	2	DOID:4621 (implicated_via_orthology)
Disease	severe acute respiratory syndrome, COVID-19	RELN PRR5L RAP1GAP2 FBXO47 PXDN PTPRD SYNJ2 ALCAM SLC23A2 MXRA5 TRPC7 CSMD1	8.13e-04	447	266	12	EFO_0000694, MONDO_0100096
Disease	osteoarthritis	RELN CYP2S1 CSMD3 NFKB1 DNAH10 CRY1 SLC25A13 SENP6	9.65e-04	222	266	8	MONDO_0005178
Disease	cortical thickness	CPA4 RELN SLC12A8 ADGRV1 STOX1 PCDH17 FBN1 MAST4 WNT3A NFKB1 ALCAM CLUH HSPG2 NSF EBF1 NR2F2 KLHL38 THBS3 PAM MAPK3 ABHD12	1.24e-03	1113	266	21	EFO_0004840
Disease	urinary albumin to creatinine ratio	BAHCC1 MGAM CUBN EDEM3 THBS3 SBF2 PDGFD	1.25e-03	179	266	7	EFO_0007778
Disease	uric acid measurement	PIGN ADGRV1 NFATC2 NFKB1 SLC27A5 LRRC8C CDC42BPG FAT4 DNAJC13 DUSP9 CUBN CEMIP SLC20A2 SBF2	1.39e-03	610	266	14	EFO_0004761
Disease	Left ventricular mass to end-diastolic volume ratio	PXDN NSF SLC35F1	1.44e-03	25	266	3	EFO_0010556
Disease	comparative body size at age 10, self-reported	RELN DLK1 WNK1 ADCY8 SLC35D1 EBF2 MAST4 EBF1 MED13L EDEM3 CSMD1	1.62e-03	420	266	11	EFO_0009819
Disease	alpha 1-antitrypsin deficiency (implicated_via_orthology)	SERPINA12 SYVN1	1.65e-03	7	266	2	DOID:13372 (implicated_via_orthology)
Disease	infertility (implicated_via_orthology)	BRCA2 CSF1R	1.65e-03	7	266	2	DOID:5223 (implicated_via_orthology)
Disease	Drug Withdrawal Symptoms	ADCY8 FAAH SLC6A1 MAPK3	1.87e-03	58	266	4	C0086189
Disease	Withdrawal Symptoms	ADCY8 FAAH SLC6A1 MAPK3	1.87e-03	58	266	4	C0087169
Disease	Substance Withdrawal Syndrome	ADCY8 FAAH SLC6A1 MAPK3	1.87e-03	58	266	4	C0038587
Disease	Liver Cirrhosis, Experimental	GLT8D1 DAO CEMIP2 FBN1 PXDN PTPRD SLC22A8 NOCT MMP8 MAP3K8 GPAM ATP10D CRY1 CSF1R PLPP2 SLC25A13	1.90e-03	774	266	16	C0023893
Disease	Varicose veins	PIEZO1 ADGRV1 NFATC2 ROR2 CNRIP1 EBF1 SBF2	1.92e-03	193	266	7	HP_0002619
Disease	PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME	KDM5C PAK3	2.19e-03	8	266	2	C0796250
Disease	Aqueductal Stenosis	MYH10 HYDIN	2.19e-03	8	266	2	C2936786
Disease	kallistatin measurement	SERPINA12 SERPINA5	2.19e-03	8	266	2	EFO_0008196
Disease	mesangial proliferative glomerulonephritis (biomarker_via_orthology)	FBN1 PDGFD	2.19e-03	8	266	2	DOID:4783 (biomarker_via_orthology)
Disease	Strabismus	PTPRD DNAH5 CSMD1	2.23e-03	29	266	3	HP_0000486
Disease	Liver Cirrhosis	F3 ABCB4 FBN1 SLC22A8 CP	2.45e-03	103	266	5	C0023890
Disease	type 2 diabetes mellitus (implicated_via_orthology)	PIK3CD SERPINA12 NR2F2 MTR MAPK3	2.66e-03	105	266	5	DOID:9352 (implicated_via_orthology)
Disease	Fibrosis, Liver	F3 ABCB4 FBN1 SLC22A8 CP	2.66e-03	105	266	5	C0239946
Disease	Autistic Disorder	RELN KDM5C DAO CSMD3 CP GRIK2 NLGN1 MAPK3	2.66e-03	261	266	8	C0004352
Disease	total blood protein measurement	ZBTB38 F3 CEMIP2 NFKB1 DNAJC13 EBF1 NSUN7 CSF1R SBF2 HYDIN SERPINA5	2.71e-03	449	266	11	EFO_0004536
Disease	cystic fibrosis (implicated_via_orthology)	ABCB4 ABCC12	2.80e-03	9	266	2	DOID:1485 (implicated_via_orthology)
Disease	Spastic Paraplegia	ARL6IP1 RAB3GAP2	2.80e-03	9	266	2	C0037772
Disease	glycosyl-N-stearoyl-sphingosine (d18:1/18:0) measurement	CNGA1 ATP10D	2.80e-03	9	266	2	EFO_0800275
Disease	Antihypertensive use measurement	ADCY8 EBF2 NFATC2 WNT3A HSPG2 NLGN1 EBF1 SBF2	2.92e-03	265	266	8	EFO_0009927
Disease	Dupuytren Contracture	DCHS2 EBF2 PXDN NFATC2 EBF1	3.01e-03	108	266	5	EFO_0004229
Disease	age at menarche	MYO10 TRPC6 DLK1 WDR25 ADCY8 PTPRD RBMS3 SLC27A5 CPA5 SENP6 GREB1 MAPK3 CSMD1	3.07e-03	594	266	13	EFO_0004703
Disease	cancer (implicated_via_orthology)	CAND1 CDS2 BRCA2 PIK3CD HACD2 LCK CSF1R MAPK3	3.13e-03	268	266	8	DOID:162 (implicated_via_orthology)
Disease	MYELODYSPLASTIC SYNDROME	DLK1 BRCA2 CSF1R CSF3R	3.17e-03	67	266	4	C3463824
Disease	threonate measurement	SLC23A2 SLC6A1	3.47e-03	10	266	2	EFO_0021032
Disease	obesity (implicated_via_orthology)	DCHS2 MED13 FAT4 SDK2 DNAH10 MED13L SERPINA12	3.49e-03	215	266	7	DOID:9970 (implicated_via_orthology)
Disease	R-6-hydroxywarfarin measurement	CDS2 PTPRD CARD6 MTR PCDH9	3.79e-03	114	266	5	EFO_0803327
Disease	emphysema	BICD1 DHX15 CSMD1	3.83e-03	35	266	3	EFO_0000464
Disease	Manic Disorder	RELN TRPC3 STARD9 GRIK2	3.91e-03	71	266	4	C0024713
Disease	Prescription Drug Abuse	CSMD3 FAAH ZNF606 GRIK2 CSMD1	3.93e-03	115	266	5	C4316881
Disease	Substance-Related Disorders	CSMD3 FAAH ZNF606 GRIK2 CSMD1	3.93e-03	115	266	5	C0236969
Disease	Organic Mental Disorders, Substance-Induced	CSMD3 FAAH ZNF606 GRIK2 CSMD1	3.93e-03	115	266	5	C0029231
Disease	Drug habituation	CSMD3 FAAH ZNF606 GRIK2 CSMD1	3.93e-03	115	266	5	C0013170
Disease	Drug abuse	CSMD3 FAAH ZNF606 GRIK2 CSMD1	3.93e-03	115	266	5	C0013146
Disease	Drug Use Disorders	CSMD3 FAAH ZNF606 GRIK2 CSMD1	3.93e-03	115	266	5	C0013222
Disease	Drug Dependence	CSMD3 FAAH ZNF606 GRIK2 CSMD1	3.93e-03	115	266	5	C1510472
Disease	Substance Dependence	CSMD3 FAAH ZNF606 GRIK2 CSMD1	3.93e-03	115	266	5	C0038580
Disease	Substance Use Disorders	CSMD3 FAAH ZNF606 GRIK2 CSMD1	3.93e-03	115	266	5	C0038586
Disease	Substance abuse problem	CSMD3 FAAH ZNF606 GRIK2 CSMD1	4.08e-03	116	266	5	C0740858
Disease	Primary ciliary dyskinesia	DNAH5 RSPH3 HYDIN	4.15e-03	36	266	3	cv:C0008780
Disease	Bipolar I disorder	DAO TRPC7	4.22e-03	11	266	2	C0853193
Disease	Leukoencephalopathy	CSF1R MTR	4.22e-03	11	266	2	C0270612
Disease	visceral adipose tissue measurement	DLK1 WNK1 ADCY8 PCDH17 EBF2 SLC22A8 GPR158 ALCAM DNAH10 ROR2 NLGN1	4.54e-03	481	266	11	EFO_0004765
Disease	cognitive decline measurement	RELN CEMIP2 NIT2 PTPRD ALCAM GRIK2 EBF1 MED13L TBC1D8 TMEM132D PCDH9	4.90e-03	486	266	11	EFO_0007710
Disease	decanoylcarnitine measurement	SLC6A1 DHX34	5.03e-03	12	266	2	EFO_0021039
Disease	response to vaccine	MEX3C PTPRD GPR158 DNAH9 CSMD1	5.05e-03	122	266	5	EFO_0004645
Disease	pursuit maintenance gain measurement	PTPRD SDK2 NLGN4Y GRIK2 CSMD1	5.23e-03	123	266	5	EFO_0008433
Disease	BMI-adjusted waist circumference, physical activity measurement	ZBTB38 CABLES1 CPA5 DNAH10 CPA1	5.23e-03	123	266	5	EFO_0007789, EFO_0008002
Disease	breast carcinoma	ZBTB38 ADCY8 CABLES1 EBF2 FBN1 PTPRD BRCA2 ALCAM BAHCC1 NSF POLR2B GRIK1 EBF1 KLHL38 SBF2 GREB1 SPAG17 GAB1	5.39e-03	1019	266	18	EFO_0000305
Disease	Manic	RELN TRPC3 STARD9 GRIK2	5.46e-03	78	266	4	C0338831
Disease	multiple system atrophy	FBXO47 EBF2 CARD6	5.60e-03	40	266	3	EFO_1001050
Disease	unipolar depression, age at onset	TM9SF2 ALCAM LRRC8C	5.60e-03	40	266	3	EFO_0003761, EFO_0004847
Disease	Depression, Bipolar	RELN TRPC3 STARD9 GRIK2	5.72e-03	79	266	4	C0005587
Disease	QRS duration	F3 PTPRD GPR158 FAT4 DEFB135 SLC35F1 KLHL38 OR52H1	5.88e-03	298	266	8	EFO_0005055
Disease	mood disorder	RELN SORL1	5.91e-03	13	266	2	EFO_0004247
Disease	illegal drug consumption	TMEM132D CSMD1	5.91e-03	13	266	2	EFO_0005431
Disease	Charcot-Marie-Tooth disease type 4	PRX SBF2	5.91e-03	13	266	2	cv:C4082197
Disease	kidney disease (implicated_via_orthology)	TRPC6 LCK CUBN	6.00e-03	41	266	3	DOID:557 (implicated_via_orthology)
Disease	testosterone measurement	DCHS2 DAO DLK1 CSMD3 SLC22A7 EBF2 SLC22A8 RBMS3 NFKB1 PGAP1 USH2A TRPC7 AKNA GPAM EBF1 TBC1D8 ZC3H7A SLC20A2 SBF2 GREB1 TPBG	6.03e-03	1275	266	21	EFO_0004908
Disease	erectile dysfunction	PDPK1 ALCAM EBF3	6.42e-03	42	266	3	EFO_0004234
Disease	Hodgkins lymphoma	DLK1 FCGBP PDGFD MAPK3	6.52e-03	82	266	4	EFO_0000183
Disease	Schizophrenia	RELN HTR3E DAO BCL9 PCDH17 CP GRIK1 GRIK2 NLGN1 PITPNM1 SLC6A1 SLC18A2 MTR MAPK3 CSMD1 RIMS2	6.73e-03	883	266	16	C0036341
Disease	retinal nerve fibre layer thickness measurement	ARHGAP22 PTPRD NSF	6.85e-03	43	266	3	EFO_0600004
Disease	ascorbic acid 3-sulfate measurement	SLC23A2 MAPK3	6.86e-03	14	266	2	EFO_0800173
Disease	Childhood Ataxia with Central Nervous System Hypomyelinization	CSF1R MTR	6.86e-03	14	266	2	C1858991
Disease	body weights and measures, parental genotype effect measurement	FES EBF1	6.86e-03	14	266	2	EFO_0004324, EFO_0005939
Disease	Alzheimer disease, visuospatial impairment	NIT2 CSMD1	6.86e-03	14	266	2	EFO_0009752, MONDO_0004975

Protein segments in the cluster

Peptide	Gene	Start	Entry
KTYFLLGRVQPNPFI	ADCY8	1166	P40145
QIFYPSGNLAIIRVP	ERICH6	446	Q7L0X2
SRLFQPVQYGQKPEG	EP400	1461	Q96L91
SVLQIVSAPGQPYLR	EP400	1656	Q96L91
AVFLSAGRPNLPYIG	BAHCC1	2521	Q9P281
LINGTNFPFGIPQVY	BAAT	256	Q14032
GPGAEPFYIRANLTL	CARD10	701	Q9BWT7
LRLSGKPQNAPEGYQ	CDC20	131	Q12834
TSGASYLQNLLRVPP	BICD1	871	Q96G01
PLIGSYQGSQAPERI	CSMD1	1516	Q96PZ7
FTQRRGTILSPGYPE	CSMD1	1806	Q96PZ7
LPPTINAGLYGNFRA	CSMD3	1141	Q7Z407
PPGNGIYINFTVLQT	CSMD3	2316	Q7Z407
RPSLYVINLLVPSGF	HTR3E	246	A5X5Y0
ALSFYLPVKSGNRVP	HTR3E	266	A5X5Y0
ILAFPQRQESYLGPT	ABHD11	246	Q8NFV4
LQPRGGTSPYNTLIA	ADGRL1	1191	O94910
RYGFLLPASQIIPTA	CPA1	386	P15085
QYLLEQEVPGSRVGP	EHD2	76	Q9NZN4
LGISILYRKPNGTNP	GRIK1	551	P39086
LQGLDGPVFTQPKYI	FAT4	1621	Q6V0I7
TFPPGRATVIYNLTV	ADGRV1	206	Q8WXG9
PNALPFRGIYGISNL	ADGRV1	5271	Q8WXG9
PSDLFRLQEYNIPGV	CDS2	306	O95674
YIASFIRGPNPSKLI	CDS2	396	O95674
ARLPQLGTVGQSPYT	TFAP2A	26	P05549
PTIDYGFQRLQKVIP	EBF2	341	Q9HAK2
TLIGRQSPQLPQAFY	PAM	256	P19021
DYLVPILAPRIFGSN	ARL6IP1	81	Q15041
LAERSLGPQLYGVFP	CHKB	126	Q9Y259
QIYFDNCPLLTIPGR	DHX15	301	O43143
SPQQVTRLPSGYGLA	DLK1	251	P80370
QNFPIRGIQLYDGPI	CEMIP	871	Q8WUJ3
PPQYSLLKQGEGFSV	DMWD	251	Q09019
DFRLQPIYTPNGGIN	FLRT2	621	O43155
LLQQIPDVSPTGRYT	ATP8A1	86	Q9Y2Q0
VYRVLQGSLFPSPIL	ATP10D	1316	Q9P241
LYGPTNVAPIINRVA	CPNE6	406	O95741
GIQAIYGLSSNPIQP	MMP8	256	P22894
AAAYRVTLNPPGTFL	NDUFA11	36	Q86Y39
QPSVSLGAPYRGQLA	RBM14	276	Q96PK6
NDNPPRFTKGLYVLQ	PCDH17	466	O14917
LLYNGQKRVPGSPTN	HSPG2	3701	P98160
TNLYIRGLPPGTTDQ	RBMS3	61	Q6XE24
SQYPNQPTRFGKLLL	NR2F2	351	P24468
GSQANRLFYLALPPT	G6PD	131	P11413
YGQGRNPFFLEPSIL	INTS6L	111	Q5JSJ4
TEFALQLLAPGTYQP	NUDT8	186	Q8WV74
QLLAPGTYQPRLAGL	NUDT8	191	Q8WV74
VRPLNPEGSLFLYGT	CDC42BPG	1356	Q6DT37
RGIYNSPYIIPGTQT	DAO	221	P14920
GQPPQLLIYEVSNRF	IGKV2D-29	66	A0A075B6S2
PLDILITGQFYDRPS	LILRA2	311	Q8N149
ITGQFYDRPSLSVQP	LILRA2	316	Q8N149
VPFQLGRKLYSIAAP	ABHD12	336	Q8N2K0
LAGLTPGNSPIFYRE	ABHD14A	71	Q9BUJ0
YPLSIEPIGVRFNKN	CP	471	P00450
QGPSRVAQFLVIYAP	RAB3GAP2	456	Q9H2M9
VVLLRYQFSRPGPQS	FCHO1	736	O14526
ISLPYTSNGLQITPF	MUC6	121	Q6W4X9
QGQRLSPGSYPTVIQ	NFATC2	851	Q13469
NPLRALYLIATNGTP	PAK3	481	O75914
LFFGAGTITYLQPKP	OR10AG1	241	Q8NH19
RGIFILSPNYVNGPS	IL18RAP	476	O95256
LSPNYVNGPSIFELQ	IL18RAP	481	O95256
ILNIYAPNTGAPRFI	nan	111	O00370
PQFEKTLEQTPRGYL	ENTPD5	211	O75356
PFQVLVSPYGLNGTL	MED13L	206	Q71F56
VPVNPALYGNGLELQ	MED13L	576	Q71F56
PSRQSYVLVGKLDFP	MAGEB17	171	A8MXT2
LELRGVVFPYQSPNG	HAPLN3	161	Q96S86
YVQIGFPPLLSIVSR	GEMIN2	171	O14893
PPQIGKTGAYLQFLS	GREB1	1346	Q4ZG55
LTLSLEGVVFPYQPS	HAPLN2	141	Q9GZV7
LQPAPAITYRTIGGI	MGAM2	286	Q2M2H8
PGTAPKLLIYGNSNR	IGLV1-50	61	A0A075B6I6
KLLIYGNSNRPSGVP	IGLV1-50	66	A0A075B6I6
RSYPGLLVVPQAVQD	SBF2	1151	Q86WG5
SSAIYGLQPNLVPEF	GPR158	286	Q5T848
TYQIPRTFPEGTLGQ	GAB1	316	Q13480
ESVQLNLAPPGYFLL	DOP1B	1791	Q9Y3R5
LQPAPAITYRTIGGI	MGAM	331	O43451
RPINLEPIFQGYIDS	KRT2	221	P35908
TTSGLPYPRINLKFG	EDEM3	196	Q9BZQ6
TGQYGFLLPATQIIP	CPA5	401	Q8WXQ8
PYGVFTINPRTGEIN	DSG4	96	Q86SJ6
GNLPEYLPFVLQEIT	CAND1	886	Q86VP6
LLYLNQSVPPYGVAL	CPSF1	286	Q10570
FRGYTLPQGTEVFPL	CYP2S1	381	Q96SQ9
LAGYFNLVRGPPTLE	MAP3K8	451	P41279
IQVKGNGYVQSPRFP	PDGFD	56	Q9GZP0
PNIDLRYIISPINGT	PCDH9	356	Q9HC56
TLGIPPTQLSKYGNL	COG8	526	Q96MW5
ASFPVQILPNLYLGS	DUSP9	201	Q99956
IGSILASVNPYQPIA	MYO10	96	Q9HD67
LSEVPQGIPSNTRYL	LRRC4	66	Q9HBW1
LDNGGFYISPRITFP	LCK	186	P06239
YVPIGPRFSNLVLQA	NSF	611	P46459
GSITTPPLLIVFYQQ	GLT8D1	281	Q68CQ7
VKGQPFDVGPRYTQL	MAPK3	31	P27361
VPNFLSQTQGYLRSP	MROH6	596	A6NGR9
YQLVAGLPPFRAGNE	PDPK2P	246	Q6A1A2
NEILGPVIQFLGVPY	NLGN1	71	Q8N2Q7
GTPFLNPLIYTLRNA	OR4C11	276	Q6IEV9
PFAILTLVNAPYKRG	PLPP2	21	O43688
PPQVGKTGSYLQFLR	GREB1L	1321	Q9C091
PSLYIFVIGVGLPTN	GPR4	21	P46093
LIPQFGLFSKYRTPN	SPINK2	21	P20155
AGFVPVYLRQTPNDL	NAT10	726	Q9H0A0
LYFQGPSSNKPRVIR	MCM7	136	P33993
PRSQPVLLQYSLNGG	RELN	2241	P78509
FNYPTRANVPVLQGL	ABCB4	1041	P21439
DVRNGIYPLTAFGLP	NRBP1	396	Q9UHY1
NGLIRYSIASPQPGV	DCHS2	1011	Q6V1P9
TLPTLQAIFYPVQGQ	PRR5L	136	Q6MZQ0
PLYQQLLSFEESPQG	RIMS2	1321	Q9UQ26
NYGKIQGLRTPLPSE	NLGN4Y	51	Q8NFZ3
LRNKIGSLAQPGPYE	PAX1	221	P15863
PLTIAGPVLLNFYSN	CUBN	3006	O60494
LGLNPYPGILVNSKF	CSF1R	851	P07333
VSKPPLINGLYTNRT	IGSF10	2231	Q6WRI0
PQGPFSIRAGYSIII	HYDIN	5026	Q4G0P3
PSPGVYRLFIQNVAV	IGSF3	896	O75054
QNLYGTPVFRPVLEN	CARD6	716	Q9BX69
KYSILQQTPRSPGLF	DSC3	281	Q14574
QRVFPQPGSLYLAKT	BRCA2	2501	P51587
GILPIAFSRPTSQNY	CABLES1	246	Q8TDN4
PAGDVLRVTLQPYNV	FCGBP	186	Q9Y6R7
QRPGFVIDIYTGLPV	FBN1	1751	P35555
LYGIFPQGRLEQFIP	CHKA	196	P35790
RYTPLPLGGNKEQAI	GAS2L2	586	Q8NHY3
SQTLQYFPRGEVPGR	BCL9	1246	O00512
TGTYGFLLPANQIIP	CPA4	386	Q9UI42
SIALRIQPNDGPVFY	CNRIP1	11	Q96F85
LPFVRQAGLYSISLP	HACD2	191	Q6Y1H2
GVPYQGNATALFILP	SERPINA5	256	P05154
QLSRPEGLNLEPVYF	CDON	461	Q4KMG0
LNGGQPPLTYKRFQT	CRY1	141	Q16526
VVLNLLFYVPPGRSG	DEFB135	11	Q30KP9
PGRSGPNVYIQKIFA	DEFB135	21	Q30KP9
RGQLNYPLPDFSKVG	AKNA	351	Q7Z591
AKPELTPLGIFYNNR	CEMIP2	706	Q9UHN6
KGTPGRFIYTALNEP	EBF1	336	Q9UH73
PTLVQTYVLQGDPRA	CSF3R	721	Q99062
QDNPQLPRLYLSGVF	DNAJC13	1111	O75165
LTGRYLLPNPVAGQA	MAST4	171	O15021
RLLYIIFGPISPQDG	FBXO47	251	Q5MNV8
RINGQPISPELFTKY	FPGS	141	Q05932
PGLERALQQYTLEPS	COPG1	556	Q9Y678
SQAPRQGLLYGVPVS	FAAH	126	O00519
PATVSRAGILYINPA	DNAH9	2276	Q9NYC9
PTIDYGFQRLQKVIP	EBF3	351	Q9H4W6
LGISILYRKPNGTNP	GRIK2	536	Q13002
YIRTGFINLDKPSNP	DKC1	86	O60832
SYFSNAPVVQVPGRL	DHX34	321	Q14147
LEQFPVPLGYDNNIT	DNAH10	3811	Q8IVF4
LRFAYPQALPNTTLG	SLC22A7	81	Q9Y694
TGEVQPFIPNIIYGI	SLC22A8	466	Q8TCC7
FIGYSPELLQNNTLP	SLC12A8	211	A0AV02
APQFPNGILEGYRLV	SDK2	1746	Q58EX2
VPNGLRALPVFYAAT	SLC20A2	176	Q08357
LQTLAGPLQTPRYFA	SBK3	101	P0C264
FLFYLPGQPEGIRSS	ALCAM	281	Q13740
PAPGVQGYSVLNSLV	CABP2	41	Q9NPB3
QRYEILTPNAIPKGF	MYH10	726	P35580
LLSRLGYQGTFFPKP	NOCT	206	Q9UK39
GKIFTALPLGNPIYQ	FPGT	141	O14772
LFGLPATQYPQLLEI	DNAH5	1391	Q8TE73
VPIPAKTYELFLNGG	NPHP1	501	O15259
TFILVGLPTAPGLQY	OR6B2	11	Q6IFH4
PGTSYRLQGLKPNSL	PTPRD	566	P23468
NLSSYNPGPFILVGI	OR52H1	11	Q8NGJ2
PGQRPSFSTIYQELQ	FES	801	P07332
AQRAQPYGITSPGIF	MS4A12	46	Q9NXJ0
SLRAQSPIPNLYLTG	RETSAT	551	Q6NUM9
SPIPNLYLTGQDIFT	RETSAT	556	Q6NUM9
INQYLTVLASLGPPR	SYVN1	521	Q86TM6
SAPGKPNGIVSLYRL	USH2A	4756	O75445
LFLVRVVVPYQGPSS	SORL1	1906	Q92673
AVGLRFNPVLYPKAS	RAP1GAP2	231	Q684P5
LPGAKEGILFYITPN	SLC6A1	261	P30531
PETYQARLQQSFPGI	RNASEH2A	146	O75792
GPPLQRIGSIFLYQT	TMEM132D	261	Q14C87
YSILQTARLLPGAPQ	SYNJ2	1136	O15056
PGTAPKLLIYGNSNR	IGLV1-40	61	P01703
KLLIYGNSNRPSGVP	IGLV1-40	66	P01703
GQLQTPQPRYLAEGT	RNF165	146	Q6ZSG1
FQDLGNKGQPYRLSP	NSUN7	456	Q8NE18
IIYQLVAGLPPFRAG	PDPK1	271	O15530
VAGLPPFRAGNEYLI	PDPK1	276	O15530
FRQYASLTGTQALPP	GANAB	376	Q14697
PIIPQGSYFLITDIS	KYAT1	331	Q16773
PSIPSLGLRNVIYIN	GPAM	81	Q9HCL2
YGEQKTLFIFPGLLP	GPR108	131	Q9NPR9
TFPIPYILADNLGLN	MEP1A	76	Q16819
VGLPIYIPAFSNGTN	MEX3C	571	Q5U5Q3
LLSGLEPFRIGPYTN	MTR	356	Q99707
EPFRIGPYTNFVNIG	MTR	361	Q99707
PLSNGLQLYSNTGIP	SLAIN1	491	Q8ND83
YISVGSQPSPILEFL	POLR2B	531	P30876
LLQQPGTDTPQGRLY	SAMD10	81	Q9BYL1
LLVTGRYTPQTLPVG	SETD1B	191	Q9UPS6
QLLVYPGAFNLTTGP	NIT2	171	Q9NQR4
IPVLFLPGNAGSYKQ	PGAP1	86	Q75T13
VQPGPFRTLLQFLYT	RHOBTB1	406	O94844
DGPIPTLKGYFLNFL	ROR2	51	Q01974
LPGTKPAYERFQLVA	STARD9	1996	Q9P2P6
PNILQQPLALGYFVS	MED13	2056	Q9UHV7
PLPLLYFGNQITGLF	SLC35D1	111	Q9NTN3
PQDPVLFVGTVRYNL	ABCC12	1201	Q96J65
GTVPLARLQPRTFYN	PLA2G3	266	Q9NZ20
PILFNLYGQPVAAGD	RRP12	691	Q5JTH9
LPQFSSIEYVVLRGP	SEC23A	111	Q15436
GTYQVLPPNTGSLYI	SPAG17	1526	Q6Q759
VQRLSTYDNVPAPGL	ARHGAP22	486	Q7Z5H3
YNPGRNIFLSPLSIS	SERPINA12	66	Q8IW75
RYPQAPLLAVGISFG	ABHD1	191	Q96SE0
LIGLNPVGPESQIRY	BPIFB2	191	Q8N4F0
VTRYLNIFGESQPNP	SLC25A13	41	Q9UJS0
AQPGQTSPLLQYFGI	CLTC	406	Q00610
SPLVVYANIRQGASP	CLCA1	606	A8K7I4
GTPIPFDKILYNRQQ	COL10A1	566	Q03692
GPSQREQYLPGAIAL	CNGA1	71	P29973
EGTSFLLRVYFQPGP	CNNM1	66	Q9NRU3
IYRNGSSANIPPLKF	CLUH	1211	O75153
ASPRYLQPGGEQLAI	SPATA13	126	Q96N96
VPRYQKFPLGDGSSL	PITPNM1	756	O00562
RSGPLPGEVNTYQIQ	RINL	86	Q6ZS11
VYKQFRNPSGPVVDL	SLC35F1	366	Q5T1Q4
FGLERYIVSQVLPNP	SKA3	161	Q8IX90
NTYALQTGPLLGRPD	RSPH3	201	Q86UC2
DFARPLLPNTVYIGG	UGT3A1	256	Q6NUS8
PLLILFSDGTVNPQY	TXNDC16	631	Q9P2K2
SLPVQALTGLIRPQY	ZC3H6	1131	P61129
PYFPRFGQKITVLIG	TAFAZZIN	196	Q16635
FGLVLPSYLRQNPLV	SLC23A2	526	Q9UGH3
PSYLRQNPLVTGITG	SLC23A2	531	Q9UGH3
SQQPFVGYRGPRELS	SLC27A5	501	Q9Y2P5
GTPASQLYPQSRGLV	KIF3B	731	O15066
FQNLGLLDYPVGVNP	STOX1	666	Q6ZVD7
GPNTYNILPGSRLQS	STPG3	231	Q8N7X2
PRTLLLYKSPQDGFG	ARHGAP23	41	Q9P227
AGYRVQVPQVTLSLP	PRX	1181	Q9BXM0
PFRILLQVPGSQVYS	TBC1D8	61	O95759
EGQVTFTQLGSYPLP	ZNF398	321	Q8TD17
LPYVSNILSPAGQIF	ZBTB18	356	Q99592
AGQTYAVPFIQPDLR	WASHC1	11	A8K0Z3
DPRVNITPSGGLYIQ	PXDN	386	Q92626
DIPLVIRPYGSSQAF	USP47	326	Q96K76
SGPKRFPLVDVLQYA	USP25	441	Q9UHP3
RQTPKLLYPLGGQTN	NUP188	496	Q5SRE5
LPTGVYLNFPVSRNA	PIK3CD	26	O00329
YIILIFQNGLDPPAN	SENP6	546	Q9GZR1
KNGRIYTLTGVLIPP	STAB2	641	Q8WWQ8
QSYSLGPDQIGPLRS	STAM2	416	O75886
GTEILAPLQNIYRGP	VWA5A	366	O00534
IYLTNGQPSIERFPI	VASH2	166	Q86V25
GVYFRVGTQPLNPSL	TECPR2	1236	O15040
GPPGYLLQRLTKTFS	TECPR2	1371	O15040
FAGIQQANPILGPIY	PKD2L2	456	Q9NZM6
EFTPYLETNLGQPTI	F3	131	P13726
IYLLSTFRLPPKQGG	THBS3	56	P49746
FPLNSVGILPVDYLN	PIGN	336	O95427
GFSLPPQYSGLDRII	TRIM60	276	Q495X7
PQYSGLDRIIKPFQV	TRIM60	281	Q495X7
KEGLQFIQSPLSYPG	ZC3H7A	16	Q8IWR0
QPLQTVLNQLFPGYG	UHRF1	776	Q96T88
LGQVLFGERIEPSPY	TM9SF2	96	Q99805
LAVGPQYSSLGSQPI	WNT3A	26	P56704
GRVGIFPNNYVIPIF	SH3RF2	426	Q8TEC5
PTDLPAYVRNLFLTG	TPBG	86	Q13641
ISQSLLYRGPVDPAN	PIEZO1	901	Q92508
NYRNLVSLGLPFTKP	ZNF354A	46	O60765
IPGGNQRFLENYPTI	ZBTB38	401	Q8NAP3
AYILPANESFGPLQI	TRPC6	611	Q9Y210
PREPVFLAQTNGNYL	WDR25	436	Q64LD2
LSSGDVLYQGFPPRL	WNK1	936	Q9H4A3
NPRGKVLYTFLVDGP	ZSWIM1	86	Q9BR11
INGRKLFGTPFYPLI	TUT4	1256	Q5TAX3
NPFIGLLTNRIGYPI	SLC18A2	146	Q05940
LLTNRIGYPIPIFAG	SLC18A2	151	Q05940
PPDFYTNGLGLINLT	VSIG2	126	Q96IQ7
QNLGPLGPFTQYLVD	TMEM254	41	Q8TBM7
SVTPVLRGQPIYIQF	PTBP1	116	P26599
FPSQGPRFIIQGYKT	TRAV4	56	A0A0B4J268
YPFIVTLEGNALQGP	ZNF449	246	Q6P9G9
IAYILPANESFGPLQ	TRPC3	541	Q13507
SVLLYGQPVRGSPFR	TRIM3	401	O75382
SELQRLYPNGVPFKV	UBXN11	271	Q5T124
LYPNGVPFKVSDLRN	UBXN11	276	Q5T124
PIYPARIQTGDNLFK	ZNF606	276	Q8WXB4
AYILPANESFGPLQI	TRPC7	556	Q9HCX4
GARSLLSPEGYQLPQ	XKR8	356	Q9H6D3
LTPKQGYFLQPERVA	TTLL13	756	A6NNM8
VPPRNSYQDFLILLG	KLHL38	276	Q2WGJ6
LNYPPGKNIGSLLRS	KDM5C	141	P41229
RFIPPEIGVLQSLQY	LRRC8C	696	Q8TDW0
VFPNGTLYIRNLAPK	MXRA5	2101	Q9NR99
GPYLQILEQPKQRGF	NFKB1	41	P19838